<!doctype html>
<html data-n-head-ssr lang="en-US" data-n-head="%7B%22lang%22:%7B%22ssr%22:%22en-US%22%7D%7D">
  <head>
    <title>Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug | Fox Business</title><meta data-n-head="ssr" http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta data-n-head="ssr" name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0"><meta data-n-head="ssr" charset="UTF-8"><meta data-n-head="ssr" name="format-detection" content="telephone=no"><meta data-n-head="ssr" name="msapplication-square70x70logo" content="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/mstile-70x70.png"><meta data-n-head="ssr" name="msapplication-square150x150logo" content="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/mstile-150x150.png"><meta data-n-head="ssr" name="msapplication-wide310x150logo" content="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/mstile-310x150.png"><meta data-n-head="ssr" name="msapplication-square310x310logo" content="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/mstile-310x310.png"><meta data-n-head="ssr" name="msapplication-TileColor" content="#003366"><meta data-n-head="ssr" name="theme-color" content="#003366"><meta data-n-head="ssr" data-hid="content-language" http-equiv="content-language" content="en"><meta data-n-head="ssr" data-hid="description" name="description" content="Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke."><meta data-n-head="ssr" data-hid="prism.channel" name="prism.channel" content="fbn"><meta data-n-head="ssr" data-hid="prism.section" name="prism.section" content="fox-news-health"><meta data-n-head="ssr" data-hid="prism.subsection1" name="prism.subsection1" content=""><meta data-n-head="ssr" data-hid="prism.subsection2" name="prism.subsection2" content=""><meta data-n-head="ssr" data-hid="prism.subsection3" name="prism.subsection3" content=""><meta data-n-head="ssr" data-hid="prism.subsection4" name="prism.subsection4" content=""><meta data-n-head="ssr" data-hid="prism.aggregationType" name="prism.aggregationType" content="subsection"><meta data-n-head="ssr" data-hid="prism.genre" name="prism.genre" content=""><meta data-n-head="ssr" data-hid="pagetype" name="pagetype" content="article"><meta data-n-head="ssr" data-hid="content-creator" name="content-creator" content="tiger"><meta data-n-head="ssr" data-hid="dc.creator" name="dc.creator" scheme="dcterms.creator" content="Melissa Rudy"><meta data-n-head="ssr" data-hid="dc.title" name="dc.title" content="Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug"><meta data-n-head="ssr" data-hid="dc.subject" name="dc.subject" content=""><meta data-n-head="ssr" data-hid="dcterms.abstract" name="dcterms.abstract" content="Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke."><meta data-n-head="ssr" data-hid="dc.type" name="dc.type" scheme="dcterms.DCMIType" content="Text.Article"><meta data-n-head="ssr" data-hid="dc.description" name="dc.description" content="Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke."><meta data-n-head="ssr" data-hid="dc.language" name="dc.language" scheme="dcterms.RFC4646" content="en-US"><meta data-n-head="ssr" data-hid="dc.publisher" name="dc.publisher" content="Fox Business"><meta data-n-head="ssr" data-hid="dc.format" name="dc.format" scheme="dcterms.IMT" content="text/html"><meta data-n-head="ssr" data-hid="dc.identifier" name="dc.identifier" scheme="dcterms.URI" content="urn:uri:base64:bb17cac0-daf4-5f6c-aedf-6336408c9966"><meta data-n-head="ssr" data-hid="dc.source" name="dc.source" content="FOXBusiness"><meta data-n-head="ssr" data-hid="dc.date" name="dc.date" content="2024-03-09"><meta data-n-head="ssr" data-hid="dcterms.created" name="dcterms.created" scheme="dcterms.ISO8601" content="2024-03-09T07:54:47-05:00"><meta data-n-head="ssr" data-hid="dcterms.modified" name="dcterms.modified" scheme="dcterms.ISO8601" content="2024-03-09T09:00:40-05:00"><meta data-n-head="ssr" data-hid="og:title" property="og:title" content="Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug"><meta data-n-head="ssr" data-hid="og:description" property="og:description" content="Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke."><meta data-n-head="ssr" data-hid="og:type" property="og:type" content="article"><meta data-n-head="ssr" data-hid="og:image" property="og:image" content="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/0/0/Wegovy.jpg?ve=1&amp;tl=1"><meta data-n-head="ssr" data-hid="og:url" property="og:url" content="https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug"><meta data-n-head="ssr" data-hid="og:site_name" property="og:site_name" content="Fox Business"><meta data-n-head="ssr" data-hid="fb:pages" property="fb:pages" content="12795435237"><meta data-n-head="ssr" data-hid="robots" name="robots" content="index, follow, max-image-preview:large, max-video-preview:-1"><meta data-n-head="ssr" data-hid="twitter.title" name="twitter:title" content="Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug"><meta data-n-head="ssr" data-hid="twitter.description" name="twitter:description" content="Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke."><meta data-n-head="ssr" data-hid="twitter.url" name="twitter:url" content="https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug"><meta data-n-head="ssr" data-hid="twitter.image" name="twitter:image" content="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1024/512/Wegovy.jpg?ve=1&amp;tl=1"><meta data-n-head="ssr" data-hid="twitter.site" name="twitter:site" content="@foxbusiness"><meta data-n-head="ssr" data-hid="twitter.card" name="twitter:card" content="summary_large_image"><meta data-n-head="ssr" data-hid="twitter.creator" name="twitter:creator" content="@foxbusiness"><meta data-n-head="ssr" property="fb:app_id" content="116027085089150"><meta data-n-head="ssr" property="article:opinion" content="false"><meta data-n-head="ssr" name="classification" content="/FOX NEWS/Fox News Newsedge/Fox News Health,/FOX NEWS/Fox News Health,/FOX NEWS/Fox News Health/Fox News Healthy Living/Fox News Medications,/FOX NEWS/Fox News Health/Fox News Nutrition And Fitness/Fox News Weight Loss,/FOX NEWS/Fox News Health/Fox News Nutrition And Fitness/Fox News Obesity,/FOX NEWS/Fox News Health/Fox News Heart Health,/FOX BUSINESS/Lifestyle,/FOX NEWS/Fox News Lifestyle"><meta data-n-head="ssr" name="classification-isa" content="fox-news-health,fox-news-health,fox-news-medications,fox-news-weight-loss,fox-news-obesity,fox-news-heart-health,lifestyle,fox-news-lifestyle"><meta data-n-head="ssr" name="classification-tags" content="fox-news-health,fox-news-medications,fox-news-weight-loss,fox-news-obesity,fox-news-heart-health,lifestyle,fox-news-lifestyle"><link data-n-head="ssr" href="https://fonts.gstatic.com" rel="preconnect" crossorigin="true"><link data-n-head="ssr" href="https://fonts.googleapis.com" rel="preconnect" crossorigin="true"><link data-n-head="ssr" href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,300;0,400;0,500;0,700;0,900;1,300;1,400&amp;display=swap" rel="stylesheet" crossorigin="true"><link data-n-head="ssr" rel="icon" type="image/x-icon" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/favicon.ico"><link data-n-head="ssr" rel="schema.dcterms" href="//purl.org/dc/terms/"><link data-n-head="ssr" rel="schema.prism" href="//prismstandard.org/namespaces/basic/2.1/"><link data-n-head="ssr" rel="schema.iptc" href="//iptc.org/std/nar/2006-10-01/"><link data-n-head="ssr" rel="shortcut icon" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/favicon.ico" type="image/x-icon"><link data-n-head="ssr" rel="apple-touch-icon" sizes="57x57" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-57x57.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="60x60" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-60x60.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="72x72" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-72x72.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="76x76" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-76x76.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="114x114" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-114x114.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="120x120" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-120x120.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="144x144" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-144x144.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="152x152" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-152x152.png"><link data-n-head="ssr" rel="apple-touch-icon" sizes="180x180" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/apple-touch-icon-180x180.png"><link data-n-head="ssr" rel="icon" type="image/png" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/favicon-16x16.png" sizes="16x16"><link data-n-head="ssr" rel="icon" type="image/png" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/favicon-32x32.png" sizes="32x32"><link data-n-head="ssr" rel="icon" type="image/png" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/favicon-96x96.png" sizes="96x96"><link data-n-head="ssr" rel="icon" type="image/png" href="//static.foxnews.com/static/orion/styles/img/fox-business/favicons/android-chrome-192x192.png" sizes="192x192"><link data-n-head="ssr" rel="stylesheet" href="//static.foxnews.com/static/orion/styles/css/fox-business/article.rs.css"><link data-n-head="ssr" rel="stylesheet" href="/css/print.css" media="print"><link data-n-head="ssr" rel="canonical" href="https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug"><link data-n-head="ssr" rel="shorturl" href=""><link data-n-head="ssr" rel="amphtml" href="https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug.amp"><script data-n-head="ssr" type="text/javascript">
          (function (h,o,u,n,d) {
            h=h[d]=h[d]||{q:[],onReady:function(c){h.q.push(c)}}
            d=o.createElement(u);d.async=1;d.src=n
            n=o.getElementsByTagName(u)[0];n.parentNode.insertBefore(d,n)
          })(window,document,'script','https://www.datadoghq-browser-agent.com/datadog-rum-v4.js','DD_RUM')
          DD_RUM.onReady(function() {
            DD_RUM.init({
              clientToken: 'pub1a8895ebd85c9e6f58bccc125bb05f51',
              applicationId: '3c67c224-5474-48d5-8c7e-796a69f15182',
              site: 'foxbusiness.com',
              service: 'www.foxbusiness.com',
              env: 'prod',
              // Specify a version number to identify the deployed version of your application in Datadog
              version: '1.0.0',
              sampleRate: 20,
              sessionReplaySampleRate: 0,
              trackInteractions: true,
              trackResources: true,
              trackLongTasks: true,
              defaultPrivacyLevel: 'mask-user-input',
            });

            DD_RUM.startSessionReplayRecording();
          })
        </script><script data-n-head="ssr" src="//strike.fox.com/static/fbn/display/loader.js"></script><script data-n-head="ssr" src="//static.foxnews.com/static/orion/scripts/core/ag.core.js"></script><script data-n-head="ssr" src="//static.foxnews.com/static/isa/core.js"></script><script data-n-head="ssr" src="//static.foxnews.com/static/orion/scripts/fox-business/article/loader.js"></script><script data-n-head="ssr" type="application/ld+json">
        {
          "@context": "http://schema.org",
          "@type": "NewsArticle",
          "mainEntityOfPage": "https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug",
          "headline": "Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug",
          "articleBody": "Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday. The injectable semaglutide &#x2014; originally approved for weight loss for certain patients &#x2014; is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either overweight or obese, the announcement stated.&#xA0; &quot;Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,&quot; said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA&#x2019;s Center for Drug Evaluation and Research, in the press release.&#xA0; NOVO NORDISK CEO SAYS FOOD EXECS ARE &#x2018;SCARED&#x2019; OF WEIGHT-LOSS DRUG THREAT &quot;This patient population has a higher risk of cardiovascular death, heart attack and stroke,&quot; he also said.&#xA0; &quot;Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.&quot;&#xA0;  Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated. The approval comes after a large, randomized, double-blind trial that included 17,600 participants in two groups. Both groups received &quot;standard-of-care medical treatment (e.g., management of blood pressure and cholesterol) and healthy lifestyle counseling (including diet and physical activity).&quot; DIABETES-RELATED WEIGHT-LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND In the trial, the group that took Wegovy showed a significant reduction in cardiovascular death, heart attack and stroke. Brooke Boyarsky Pratt, the CEO of knownwell, a Boston-based weight management company, said the announcement marked &quot;an exciting day&quot; for patients with heart disease as well as their doctors. &quot;This approval is an important step in getting patients access to potentially life-saving medication,&quot; Pratt said in a statement to Fox News Digital.  &quot;It continues to support what the medical community has known all along &#x2014; GLP-1s are here to treat serious chronic diseases, now cardiovascular disease in addition to diabetes and obesity.&quot; The FDA&#x2019;s approval is a step in the right direction toward battling the &quot;bias and stigma&quot; around these medications, she said. &quot;Significantly reducing the risk of cardiac disease in patients who are at a higher risk is incredibly important to both patients and clinicians,&quot; Pratt went on.&#xA0;  &quot;We hope that with this indication, these patients who unfortunately may not have had coverage for these medications before will soon find them covered.&quot; WEIGHT-LOSS MEDICATION SHORTAGE CREATES MARKET FOR BOGUS DRUGS Dr. Darren McGuire, a cardiologist at UT Southwestern in Dallas, Texas, called the FDA&#x2019;s approval a &quot;landmark decision in the field of medical therapy for obesity.&quot; He told Fox News Digital, &quot;With this FDA action, semaglutide becomes the first medication ever in the U.S. approved for the treatment of persons living with obesity with anything beyond a claim of cardiovascular safety.&quot;  The decision, McGuire said, reinforces what most medical experts have known for decades &#x2014; &quot;that reducing body weight for persons living with obesity would reduce risk for a broad spectrum of obesity-related complications, cardiovascular and otherwise.&quot;&#xA0; GET FOX BUSINESS ON THE GO BY CLICKING HERE McGuire, who is an expert in heart disease and prevention, especially among people with diabetes, predicts that approximately one in five U.S. adults would benefit from treatment with semaglutide. &quot;Conservatively, around 55 million U.S. adults have an indication for cardiovascular risk reduction with semaglutide,&quot; he said. Looking ahead, McGuire predicts that many similar medications will enter the market in years to come. FDA CHIEF SOUNDS ALARM OVER SALE OF FAKE WEIGHT-LOSS DRUGS CIRCULATING ONLINE &quot;Presently, semaglutide is only one drug in one class with proof of cardiovascular efficacy and with FDA approval for such,&quot; he told Fox News Digital. &quot;Many more medications are presently being developed and tested similarly, so this field will rapidly evolve.&quot; CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER Patients should speak with a health care provider about the potential benefits and side effects of Wegovy, experts say. Fox News Digital reached out to Novo Nordisk requesting additional comment. For more Health articles, visit www.foxnews.com/health.",
          "datePublished": "2024-03-09T08:05:50-05:00",
          "dateModified": "2024-03-09T08:05:50-05:00",
          "description": "Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.",
          "author": [{"@type":"Person","name":"Melissa Rudy","url":"https://www.foxbusiness.com/person/r/melissa-rudy"}],
          "publisher": {
            "@type": "Organization",
            "name": "Fox Business",
            "logo": {
              "@type": "ImageObject",
              "url": "https://static.foxnews.com/static/orion/styles/img/fox-business/logos/fox-business-logo.png",
              "width": "133",
              "height": "60"
            }
          },
          "image": {
            "@type": "ImageObject",
            "url": "https://static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/Wegovy.jpg"
          }
        }
      </script><script data-n-head="ssr" type="application/ld+json">
      {
        "@context": "https://schema.org",
        "@type": "VideoObject",
        "contentUrl": "https://vod.foxbusiness.com/media/v1/pmp4/static/clear/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/5791d5f3-fc7a-4f44-bcf1-5433390876d2/main.mp4",
        "description": "Barbara Ryan Advisors founder Barbara Ryan discusses the future of the biotech sector on 'Making Money.'",
        "name": "Weight loss drugs will exceed $100B in annual sales by 2030: Barbara Ryan",
        "uploadDate": "2024-02-27T16:43:44-05:00",
        "duration": "PT5M34S",
        
        "thumbnailUrl": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/image.jpg"
      }
    </script><script data-n-head="ssr" type="application/ld+json">
      {
        "@context": "https://schema.org/",
        "@type": "WebPage",
        "name": "Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug",
        "url": "https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug",
        "significantLink": ["https://www.foxbusiness.com/fox-news-health/anxiety-biggest-concern-employees-seeking-mental-health-services-study-finds-major-concern","https://www.foxbusiness.com/lifestyle/disney-parks-issue-lifetime-bans-people-lie-disabilities","https://www.foxbusiness.com/fox-news-lifestyle/artificial-beauty-warning-threats-girls-self-esteem-dove-recommits-never-using-ai-ads","https://www.foxbusiness.com/economy/bird-flu-texas-largest-us-egg-producer-temporarily-shutters-facility-h5n1-virus-found-chickens","https://www.foxbusiness.com/lifestyle/asleep-on-the-job-heres-how-many-americans-admit-napping-during-work-hours","https://www.foxbusiness.com/lifestyle/costco-launches-weight-loss-program-for-members","https://www.foxbusiness.com/media/us-plunge-bidets-four-years-toilet-paper-shortage-wiped-store-shelves","https://www.foxbusiness.com/lifestyle/boy-12-taken-hospital-mistakenly-served-alcohol-outback-steakhouse","https://www.foxbusiness.com/technology/nvidia-announces-ai-powered-health-care-agents-outperform-nurses-cost-9-hour","https://www.foxbusiness.com/small-business/real-life-cat-burglary-suspect-yoga-raiding-bakery-store-video"]
      }
    </script><link rel="preload" href="/_wzln/d848a9c.js" as="script"><link rel="preload" href="/_wzln/b4045d4.js" as="script"><link rel="preload" href="/_wzln/bcd5298.js" as="script"><link rel="preload" href="/_wzln/46ccc55.js" as="script">
  </head>
  <body class="fb article-single amp-geo-pending" data-n-head="%7B%22class%22:%7B%22ssr%22:%22fb%20article-single%20amp-geo-pending%22%7D%7D">
    <amp-geo layout="nodisplay">
        <script type="application/json">
        {
          "ISOCountryGroups": {
            "eu": ["at", "be", "bg", "cy", "cz", "de", "dk", "ee", "es", "fi", "fr", "gb", "gr", "hr", "hu", "ie", "it", "lt", "lu", "lv", "mt", "nl", "pl", "pt", "ro", "se", "si", "sk"]
          }
        }
        </script>
    </amp-geo>
    <div data-server-rendered="true" id="__nuxt"><div id="__layout"><div id="wrapper" data-fetch-key="0" class="wrapper"><header data-fetch-key="1" class="site-header"><div class="branding"><a href="/" class="logo">Fox Business</a></div> <div class="nav-row nav-row-upper"><div class="inner"><div class="primary-nav tablet-desktop"><nav id="main-nav"><ul><li class="menu-personal-finance"><a href="/personal-finance" data-omtr-intcmp="nav_personalfinance">Personal Finance</a></li><li class="menu-economy"><a href="/economy" data-omtr-intcmp="nav_economy">Economy</a></li><li class="menu-markets"><a href="/markets" data-omtr-intcmp="nav_markets">Markets</a></li><li class="menu-watchlist"><a href="/watchlist" data-omtr-intcmp="nav_watchlist">Watchlist</a></li><li class="menu-lifestyle"><a href="/lifestyle" data-omtr-intcmp="nav_lifestyle">Lifestyle</a></li><li class="menu-real-estate"><a href="/real-estate" data-omtr-intcmp="nav_real_estate">Real Estate</a></li><li class="menu-tech"><a href="/technology" data-omtr-intcmp="nav_tech">Tech</a></li><li class="menu-video"><a href="/video" data-omtr-intcmp="nav_video">Video</a></li><li class="menu-podcasts"><a href="//radio.foxnews.com/podcast" data-omtr-intcmp="nav_podcast">Podcasts</a></li> <li class="menu-more"><a href="#" class="js-menu-toggle">More</a></li></ul></nav></div> <div class="meta"><div class="search-toggle tablet-desktop"><a href="#" class="js-focus-search">Expand / Collapse search</a></div> <div id="account" class="network-access logged-out logged-in"><div class="user-profile user-login button show"><a href="#" rel="nofollow" data-omtr-intcmp="hp1navlg" class="login">Login</a></div></div> <div class="button watch"><a href="https://www.foxbusiness.com/video/5640669329001">Watch TV</a></div> <div class="menu mobile"><a href="#" class="js-menu-toggle">Menu</a></div></div></div></div> <div class="expandable-nav"><div class="inner"><div class="search"><div class="search-wrap"><form autocomplete="off" action="/search" method="get"><fieldset><input aria-label="Search foxbusiness.com" type="text" placeholder="Search foxbusiness.com" name="q" onblur onfocus autocomplete="off" value="" class="resp_site_search"> <input type="hidden" name="ss" value="fb"> <input aria-label="Submit Search" type="submit" value="Search" class="resp_site_submit"></fieldset></form></div></div></div> <div class="section-nav"><div class="inner"><nav aria-label="header nav item 1 personal-finance" class="menu-personal-finance"><div class="nav-title"><a href="/personal-finance" data-omtr-intcmp="">Personal Finance</a></div> <ul class="submenu-personal-finance"><li class="nav-item menu-mortgages"><a href="/category/mortgage" data-omtr-intcmp="">Mortgages</a></li><li class="nav-item menu-student-loans"><a href="/category/student-loans" data-omtr-intcmp="">Student Loans</a></li><li class="nav-item menu-credit-cards"><a href="/category/credit-cards" data-omtr-intcmp="">Credit Cards</a></li><li class="nav-item menu-personal-loans"><a href="/category/personal-loans" data-omtr-intcmp="">Personal Loans</a></li><li class="nav-item menu-savings"><a href="/category/savings" data-omtr-intcmp="">Savings</a></li><li class="nav-item menu-insurance"><a href="/category/insurance" data-omtr-intcmp="">Insurance</a></li><li class="nav-item menu-401k"><a href="/category/401k" data-omtr-intcmp="">401k</a></li><li class="nav-item menu-retirement"><a href="/category/modern-retirement" data-omtr-intcmp="">Retirement</a></li><li class="nav-item menu-tax-planning"><a href="/category/tax-planning" data-omtr-intcmp="">Tax Planning</a></li></ul></nav><nav aria-label="header nav item 2 economy" class="menu-economy"><div class="nav-title"><a href="/economy" data-omtr-intcmp="">Economy</a></div> <ul class="submenu-economy"><li class="nav-item menu-government-spending"><a href="/category/government-spending" data-omtr-intcmp="">Government Spending</a></li><li class="nav-item menu-money-&amp;-policy"><a href="/category/money-and-policy" data-omtr-intcmp="">Money & Policy</a></li><li class="nav-item menu-small-business"><a href="/category/small-business" data-omtr-intcmp="">Small Business</a></li><li class="nav-item menu-inflation"><a href="/category/inflation" data-omtr-intcmp="">Inflation</a></li></ul></nav><nav aria-label="header nav item 3 markets" class="menu-markets"><div class="nav-title"><a href="/markets" data-omtr-intcmp="">Markets</a></div> <ul class="submenu-markets"><li class="nav-item menu-stocks"><a href="/stocks" data-omtr-intcmp="">Stocks</a></li><li class="nav-item menu-us-markets"><a href="/category/us-markets" data-omtr-intcmp="">US Markets</a></li><li class="nav-item menu-cryptocurrency"><a href="/category/cryptocurrency" data-omtr-intcmp="">Cryptocurrency</a></li><li class="nav-item menu-futures-&amp;-commodities"><a href="/category/futures-commodities" data-omtr-intcmp="">Futures & Commodities</a></li><li class="nav-item menu-bonds"><a href="/category/bonds" data-omtr-intcmp="">Bonds</a></li><li class="nav-item menu-etfs"><a href="/category/etfs" data-omtr-intcmp="">ETFs</a></li><li class="nav-item menu-business-leaders"><a href="/category/business-leaders" data-omtr-intcmp="">Business Leaders</a></li><li class="nav-item menu-industries"><a href="/category/industries" data-omtr-intcmp="">Industries</a></li><li class="nav-item menu-retail"><a href="/category/retail" data-omtr-intcmp="">Retail</a></li><li class="nav-item menu-pre-markets"><a href="/category/pre-markets" data-omtr-intcmp="">Pre-Markets</a></li><li class="nav-item menu-mutual-funds"><a href="/category/mutual-funds" data-omtr-intcmp="">Mutual Funds</a></li></ul></nav><nav aria-label="header nav item 4 watchlist" class="menu-watchlist"><div class="nav-title"><a href="/watchlist" data-omtr-intcmp="">Watchlist</a></div> <!----></nav><nav aria-label="header nav item 5 lifestyle" class="menu-lifestyle"><div class="nav-title"><a href="/lifestyle" data-omtr-intcmp="">Lifestyle</a></div> <ul class="submenu-lifestyle"><li class="nav-item menu-entertainment"><a href="/category/entertainment" data-omtr-intcmp="">Entertainment</a></li><li class="nav-item menu-rich-&amp;-famous"><a href="/category/rich-famous" data-omtr-intcmp="">Rich & Famous</a></li><li class="nav-item menu-travel"><a href="/category/travel" data-omtr-intcmp="">Travel</a></li><li class="nav-item menu-cars"><a href="/category/cars" data-omtr-intcmp="">Cars</a></li><li class="nav-item menu-airplanes"><a href="/category/airplanes" data-omtr-intcmp="">Airplanes</a></li><li class="nav-item menu-food-&amp;-drinks"><a href="/category/food-drinks" data-omtr-intcmp="">Food & Drinks</a></li><li class="nav-item menu-arts"><a href="/category/arts" data-omtr-intcmp="">Arts</a></li></ul></nav><nav aria-label="header nav item 6 real-estate" class="menu-real-estate"><div class="nav-title"><a href="/real-estate" data-omtr-intcmp="">Real Estate</a></div> <ul class="submenu-real-estate"><li class="nav-item menu-personal"><a href="/category/personal-real-estate" data-omtr-intcmp="">Personal</a></li><li class="nav-item menu-commercial"><a href="/category/commercial-real-estate" data-omtr-intcmp="">Commercial</a></li><li class="nav-item menu-luxury-properties"><a href="/category/luxury-properties" data-omtr-intcmp="">Luxury Properties</a></li></ul></nav><nav aria-label="header nav item 7 tech" class="menu-tech"><div class="nav-title"><a href="/technology" data-omtr-intcmp="">Tech</a></div> <ul class="submenu-tech"><li class="nav-item menu-digital"><a href="/category/digital" data-omtr-intcmp="">Digital</a></li><li class="nav-item menu-social-media"><a href="/category/social-media" data-omtr-intcmp="">Social Media</a></li><li class="nav-item menu-gadgets"><a href="/category/gadgets" data-omtr-intcmp="">Gadgets</a></li><li class="nav-item menu-business-tech"><a href="/category/business-tech" data-omtr-intcmp="">Business Tech</a></li><li class="nav-item menu-healthcare-tech"><a href="/category/health-care-tech" data-omtr-intcmp="">Healthcare Tech</a></li><li class="nav-item menu-future-tech"><a href="/category/future-tech" data-omtr-intcmp="">Future Tech</a></li><li class="nav-item menu-ai"><a href="/category/artificial-intelligence" data-omtr-intcmp="">AI</a></li><li class="nav-item menu-space"><a href="/category/space-business" data-omtr-intcmp="">Space</a></li></ul></nav><nav aria-label="header nav item 8 sports" class="menu-sports"><div class="nav-title"><a href="/sports" data-omtr-intcmp="">Sports</a></div> <ul class="submenu-sports"><li class="nav-item menu-nfl"><a href="/category/nfl" data-omtr-intcmp="">NFL</a></li><li class="nav-item menu-nba"><a href="/category/nba" data-omtr-intcmp="">NBA</a></li><li class="nav-item menu-mlb"><a href="/category/mlb" data-omtr-intcmp="">MLB</a></li><li class="nav-item menu-nascar"><a href="/category/nascar" data-omtr-intcmp="">NASCAR</a></li><li class="nav-item menu-boxing"><a href="/category/boxing" data-omtr-intcmp="">Boxing</a></li><li class="nav-item menu-soccer"><a href="/category/soccer" data-omtr-intcmp="">Soccer</a></li><li class="nav-item menu-golf"><a href="/category/golf" data-omtr-intcmp="">Golf</a></li><li class="nav-item menu-tennis"><a href="/category/tennis" data-omtr-intcmp="">Tennis</a></li></ul></nav><nav aria-label="header nav item 9 opinion" class="menu-opinion"><div class="nav-title"><a href="/opinion" data-omtr-intcmp="">Opinion</a></div> <!----></nav><nav aria-label="header nav item 10 video" class="menu-video"><div class="nav-title"><a href="/video" data-omtr-intcmp="">Video</a></div> <!----></nav><nav aria-label="header nav item 11 about" class="menu-about"><div class="nav-title"><a href="/about-us" data-omtr-intcmp="">About</a></div> <ul class="submenu-about"><li class="nav-item menu-channel-finder"><a href="/channel-finder" data-omtr-intcmp="">Channel Finder</a></li><li class="nav-item menu-jobs"><a href="https://www.foxcareers.com/" data-omtr-intcmp="">Jobs</a></li><li class="nav-item menu-terms-of-use"><a href="/terms-of-use" data-omtr-intcmp="">Terms of Use</a></li><li class="nav-item menu-updated-privacy-policy"><a href="/privacy-policy" data-omtr-intcmp="">Updated Privacy Policy</a></li><li class="nav-item menu-faq"><a href="https://help.foxbusiness.com/hc/en-us/sections/4405278462107-FAQ" data-omtr-intcmp="">FAQ</a></li><li class="nav-item menu-media-relations"><a href="https://press.foxbusiness.com/media-contacts/" data-omtr-intcmp="">Media Relations</a></li><li class="nav-item menu-corporate-information"><a href="https://press.foxbusiness.com" data-omtr-intcmp="">Corporate Information</a></li><li class="nav-item menu-closed-captioning-policy"><a href="/closed-captioning" data-omtr-intcmp="">Closed Captioning Policy</a></li><li class="nav-item menu-accessibility-statement"><a href="/accessibility-statement" data-omtr-intcmp="">Accessibility Statement</a></li><li class="nav-item menu-fox-news"><a href="https://www.foxnews.com/" data-omtr-intcmp="">Fox News</a></li><li class="nav-item menu-fox-nation"><a href="https://nation.foxnews.com/" data-omtr-intcmp="">Fox Nation</a></li><li class="nav-item menu-fox-business-go"><a href="https://www.foxbusiness.com/video/5640669329001" data-omtr-intcmp="">Fox Business Go</a></li><li class="nav-item menu-apps-&amp;-products"><a href="/apps-products" data-omtr-intcmp="">Apps & Products</a></li></ul></nav></div></div> <div class="header-lower"><div class="social-icons"><ul><li class="fb"><a href="http://www.facebook.com/FoxBusiness">Facebook</a></li> <li class="tw"><a href="http://twitter.com/foxbusiness">Twitter</a></li></ul></div> <div class="branding"><a href="/" class="logo">Fox Business</a></div> <div class="legal"><ul data-fetch-key="2"><li><a href="/terms-of-use" data-omtr-intcmp="footer_termsofuse">New Terms of Use</a></li><li><a href="/privacy-policy" data-omtr-intcmp="footer_privacypolicy">New Privacy Policy</a></li><li><a href="https://privacy.foxbusiness.com/main/web/main" data-omtr-intcmp="footer_privacychoices">Your Privacy Choices</a></li><li><a href="https://help.foxbusiness.com/hc/en-us" data-omtr-intcmp="footer_help">Help</a></li><li><a href="/closed-captioning/" data-omtr-intcmp="footer_closedcaptioning">Closed Captioning Policy</a></li></ul> <div class="policy"><p>
          Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by <a href="https://www.factset.com/">Factset</a>.
          Powered and implemented by <a href="https://www.factset.com/solutions/business-needs/digital-solutions">FactSet Digital Solutions</a>. 
            <a href="https://www.factset.com/privacy">Legal Statement</a>.
          </p> <p>This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. <a href="https://help.foxbusiness.com/hc/en-us/sections/4405278462107-FAQ">FAQ</a> - <a href="/privacy-policy">New Privacy Policy</a></p></div></div></div></div></header> <div class="page"><div class="pre-content"></div> <div class="page-content"><main class="main-content"><article section="fox-news-health" tags="[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]" class="article-wrap"><!----> <header class="article-header"><div class="article-meta article-meta-upper"><div class="eyebrow"><a href="/category/fox-news-health">Health</a></div> <div class="article-date"><span class="article-date__published"><span class="article-date__label--published"><strong>Published</strong></span> <time class="article-date__time article-date__time--published">
          March 9, 2024 8:05am EST
        </time></span> <!----> <!----></div></div> <h1 class="headline">Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug</h1> <h2 class="sub-headline">The injectable semaglutide from Novo Nordisk was shown to reduce risk of cardiovascular death, heart attack and stroke</h2> <!----> <div class="article-meta article-meta-lower"><div class="social-byline"><div class="article-social "><div class="social-icons"><ul><li class="fb"><a href="#">Facebook</a></li> <li class="tw"><a href="#">Twitter</a></li> <li class="comments"><a href="#">Comments</a></li> <li class="print"><a href="#">Print</a></li> <li class="email"><a href="#">Email</a></li></ul></div></div> <div class="author-byline"><span><span class="article-authors"><span>By </span> <span class="authors"><span class="author"><a href="https://www.foxbusiness.com/person/r/melissa-rudy" rel="author">Melissa Rudy</a> <span></span></span></span></span> <span class="article-source"><a href="https://www.foxbusiness.com/">FOXBusiness</a></span></span></div></div> <!----></div></header> <div class="article-content-wrap sticky-columns"><div class="article-content"><div class="article-body"><!----> <!----> <div class="featured featured-video video-ct"><div class="contain"><div class="control"><a href="#" aria-label="top" class="top"></a> <a href="#" class="close">close</a></div> <div class="video-container"><div data-video-id="6347778473112" data-video-domain="foxbusiness" class="m video-player"><a href="http://video.foxbusiness.com/v/6347778473112"><picture><source srcset="https://a57.foxnews.com/cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/288/162/image.jpg?ve=1&amp;tl=1" media="(max-width: 767px)"> <source srcset="https://a57.foxnews.com/cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/672/378/image.jpg?ve=1&amp;tl=1" media="(min-width: 768px) and (max-width: 1023px)"> <source srcset="https://a57.foxnews.com/cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/767/450/image.jpg?ve=1&amp;tl=1" media="(min-width: 1024px) and (max-width: 1279px)"> <source srcset="https://a57.foxnews.com/cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/896/504/image.jpg?ve=1&amp;tl=1" media="(min-width: 1280px)"> <img src="https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8a599a9a-53dd-43a2-8ff7-b1e5162b025a/e280edcf-0404-42c0-bdc3-9043c3f1786f/1280x720/match/image.jpg" alt="Barbara Ryan Advisors founder Barbara Ryan discusses the future of the biotech sector on 'Making Money.'" width="896" height="500"></picture> <span class="overlay">video</span></a></div></div> <div class="info"><div class="caption"><h2 class="title"><a href="https://www.foxbusiness.com/video/6347778473112">Weight loss drugs will exceed $100B in annual sales by 2030: Barbara Ryan</a></h2> <p>Barbara Ryan Advisors founder Barbara Ryan discusses the future of the biotech sector on 'Making Money.'</p></div></div></div></div> <p>Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday.</p> <div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban1" id="mobile-mw-ad-ban1" class="ad gam inline"></div></div><p>The injectable semaglutide &#x2014; originally approved for <a href="https://www.foxnews.com/category/health/nutrition-and-fitness/weight-loss"><u>weight loss</u></a> for certain patients &#x2014; is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either overweight or obese, the announcement stated.&#xA0;</p><p>&quot;Wegovy is now the first <a href="https://www.foxnews.com/category/health/healthy-living/medications"><u>weight-loss medication</u></a> to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,&quot; said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA&#x2019;s Center for Drug Evaluation and Research, in the press release.&#xA0;</p> <p><a href="https://www.foxbusiness.com/lifestyle/ceos-ask-wegovys-novo-nordisk-for-advice-after-shift-in-trends"><strong><u>NOVO NORDISK CEO SAYS FOOD EXECS ARE &#x2018;SCARED&#x2019; OF WEIGHT-LOSS DRUG THREAT</u></strong></a></p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban2" id="mobile-mw-ad-ban2" class="ad gam inline"></div></div> <p>&quot;This patient population has a higher risk of cardiovascular death, heart attack and stroke,&quot; he also said.&#xA0;</p><div data-unit-credible=",," data-in-article="true" class="credible"></div><p>&quot;Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for <a href="https://www.foxnews.com/health"><u>public health</u></a>.&quot;&#xA0;</p><div class="inline image-ct"><div class="m"><picture><source media="(max-width: 767px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/343/192/Wegovy.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/686/384/Wegovy.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 768px) and (max-width: 1023px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/672/378/Wegovy.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1344/756/Wegovy.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1024px) and (max-width: 1279px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/931/523/Wegovy.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1862/1046/Wegovy.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1280px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/720/405/Wegovy.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1440/810/Wegovy.jpg?ve=1&amp;tl=1 2x"> <img src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/931/523/Wegovy.jpg?ve=1&amp;tl=1" alt="Wegovy"></picture></div> <div class="caption"><p><span>Novo Nordisk's blockbuster obesity medicine, Wegovy, reduced the risk of heart attacks and strokes in a highly anticipated study.</span><span> (Carsten Snejbjerg/Bloomberg via Getty Images / Getty Images)</span></p></div></div><p>Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated.</p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban3" id="mobile-mw-ad-ban3" class="ad gam inline"></div></div><p>The approval comes after a large, randomized, double-blind trial that included 17,600 participants in two groups.</p><p>Both groups received &quot;standard-of-care medical treatment (e.g., management of blood pressure and cholesterol) and healthy lifestyle counseling (including diet and physical activity).&quot;</p><p><a href="https://www.foxbusiness.com/lifestyle/diabetes-related-weight-loss-drugs-supply-issues-viral-trend"><strong><u>DIABETES-RELATED WEIGHT-LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND</u></strong></a></p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban4" id="mobile-mw-ad-ban4" class="ad gam inline"></div></div><p>In the trial, the group that took Wegovy showed a significant reduction in cardiovascular death, <a href="https://www.foxnews.com/category/health/nervous-system-health/stroke"><u>heart attack and stroke</u></a>.</p><p>Brooke Boyarsky Pratt, the CEO of knownwell, a Boston-based weight management company, said the announcement marked &quot;an exciting day&quot; for patients with <a href="https://www.foxnews.com/category/health/heart-health"><u>heart disease</u></a> as well as their doctors.</p><p>&quot;This approval is an important step in getting patients access to potentially life-saving medication,&quot; Pratt said in a statement to Fox News Digital.</p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban5" id="mobile-mw-ad-ban5" class="ad gam inline"></div></div><div class="inline image-ct"><div class="m"><picture><source media="(max-width: 767px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/343/192/Wegovy-2.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/686/384/Wegovy-2.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 768px) and (max-width: 1023px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/672/378/Wegovy-2.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1344/756/Wegovy-2.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1024px) and (max-width: 1279px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/931/523/Wegovy-2.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1862/1046/Wegovy-2.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1280px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/720/405/Wegovy-2.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/1440/810/Wegovy-2.jpg?ve=1&amp;tl=1 2x"> <img src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/08/931/523/Wegovy-2.jpg?ve=1&amp;tl=1" alt="Wegovy"></picture></div> <div class="caption"><p><span>The injectable semaglutide Wegovy was originally approved for weight loss for eligible patients.</span><span> (Steffen Trumpf/picture alliance via Getty Images / Getty Images)</span></p></div></div><p>&quot;It continues to support what the medical community has known all along &#x2014; GLP-1s are here to treat serious chronic diseases, now cardiovascular disease in addition to diabetes and obesity.&quot;</p><p>The FDA&#x2019;s approval is a step in the right direction toward battling the &quot;bias and stigma&quot; around these medications, she said.</p><p>&quot;Significantly reducing the risk of cardiac disease in patients who are at a higher risk is incredibly important to both patients and clinicians,&quot; Pratt went on.&#xA0;</p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban6" id="mobile-mw-ad-ban6" class="ad gam inline"></div></div><blockquote class="pull-quote"><p class="quote-text">This is a "landmark decision in the field of medical therapy for obesity."</p> <!----></blockquote><p>&quot;We hope that with this indication, these patients who unfortunately may not have had coverage for these medications before will soon find them covered.&quot;</p><p><a href="https://www.foxbusiness.com/lifestyle/weight-loss-medication-shortage-creates-market-bogus-drugs"><strong><u>WEIGHT-LOSS MEDICATION SHORTAGE CREATES MARKET FOR BOGUS DRUGS</u></strong></a></p><p>Dr. Darren McGuire, a cardiologist at UT Southwestern in Dallas, Texas, called the FDA&#x2019;s approval a &quot;landmark decision in the field of medical therapy for obesity.&quot;</p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban7" id="mobile-mw-ad-ban7" class="ad gam inline"></div></div><p>He told Fox News Digital, &quot;With this FDA action, semaglutide becomes the first medication ever in the U.S. approved for the treatment of persons <a href="https://www.foxnews.com/category/health/nutrition-and-fitness/obesity"><u>living with obesity</u></a> with anything beyond a claim of cardiovascular safety.&quot;</p><div class="inline image-ct"><div class="m"><picture><source media="(max-width: 767px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/343/192/Novo-Nordisk.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/686/384/Novo-Nordisk.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 768px) and (max-width: 1023px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/672/378/Novo-Nordisk.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/1344/756/Novo-Nordisk.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1024px) and (max-width: 1279px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/931/523/Novo-Nordisk.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/1862/1046/Novo-Nordisk.jpg?ve=1&amp;tl=1 2x"> <source media="(min-width: 1280px)" srcset="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/720/405/Novo-Nordisk.jpg?ve=1&amp;tl=1, https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/1440/810/Novo-Nordisk.jpg?ve=1&amp;tl=1 2x"> <img src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2023/10/931/523/Novo-Nordisk.jpg?ve=1&amp;tl=1" alt="Novo Nordisk headquarters"></picture></div> <div class="caption"><p><span>A general view of the headquarters of Danish pharmaceutical company Novo Nordisk in Copenhagen, Denmark, on Sept. 26, 2023.</span><span> (REUTERS/Tom Little/File photo / Reuters Photos)</span></p></div></div><p>The decision, McGuire said, reinforces what most medical experts have known for decades &#x2014; &quot;that reducing body weight for persons living with obesity would reduce risk for a broad spectrum of obesity-related complications, cardiovascular and otherwise.&quot;&#xA0;</p><p><a href="https://www.foxbusiness.com/apps-products"><strong><u>GET FOX BUSINESS ON THE GO BY CLICKING HERE</u></strong></a></p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban8" id="mobile-mw-ad-ban8" class="ad gam inline"></div></div><p>McGuire, who is an expert in heart disease and prevention, especially among <a href="https://www.foxnews.com/category/health/diabetes"><u>people with diabetes</u></a>, predicts that approximately one in five U.S. adults would benefit from treatment with semaglutide.</p><p>&quot;Conservatively, around 55 million U.S. adults have an indication for cardiovascular risk reduction with semaglutide,&quot; he said.</p><p>Looking ahead, McGuire predicts that many similar medications will enter the market in years to come.</p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban9" id="mobile-mw-ad-ban9" class="ad gam inline"></div></div><p><a href="https://www.foxbusiness.com/media/fda-chief-sounds-alarm-over-fake-weight-loss-drugs-circulating-online"><strong><u>FDA CHIEF SOUNDS ALARM OVER SALE OF FAKE WEIGHT-LOSS DRUGS CIRCULATING ONLINE</u></strong></a></p><p>&quot;Presently, semaglutide is only one drug in one class with proof of cardiovascular efficacy and with FDA approval for such,&quot; he told Fox News Digital. &quot;Many more medications are presently being developed and tested similarly, so this field will rapidly evolve.&quot;</p><p><a href="https://www.foxnews.com/newsletters?cmpid=fnfirstnl"><strong><u>CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER</u></strong></a></p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban10" id="mobile-mw-ad-ban10" class="ad gam inline"></div></div><p>Patients should speak with a health care provider about the potential benefits and side effects of Wegovy, experts say.</p><p>Fox News Digital reached out to Novo Nordisk requesting additional comment.</p><p><a href="https://www.foxnews.com/health"><i><strong><u>For more Health articles, visit </u></strong></i></a><a href="http://www.foxnews/health"><i><strong><u>www.foxnews.com/health</u></strong></i></a><i><strong>.</strong></i></p><div class="ad-container mobile ad-h-250 ad-w-300 ad-placeholder-load"><div data-iu="ban11" id="mobile-mw-ad-ban11" class="ad gam inline"></div></div></div> <footer class="article-footer"><!----> <!----> <div class="partners"><div class="partner geo-item"><div data-uid="fbr-ar-21" class="vendor-unit "></div></div> <div class="partner geo-item"><div data-uid="fbr-ar-22" class="vendor-unit "></div></div> <div class="partner geo-item"><div data-uid="ar-18" class="vendor-unit tablet-desktop"></div></div> <div class="partner geo-item"><div data-uid="fbr-ar-23" class="vendor-unit "></div></div> <div class="partner geo-item"><div data-uid="ar-19" class="vendor-unit tablet-desktop"></div></div> <div class="partner geo-item"><div data-uid="MB_2" class="vendor-unit mobile"></div></div></div> <div id="commenting" class="article-comments"></div></footer></div> <aside aria-label="primary sidebar" class="sidebar sidebar-primary"><div class="sticky-region"><section class="collection collection-market-indexes"><header class="heading"><h2 class="title">U.S. Stock Market Quotes</h2></header> <div class="content"><form autocomplete="off" action="/search" method="get"><fieldset><div class="input-wrap quote-lookup"><input value type="text" placeholder="Quote Lookup" name="q" onblur onfocus autocomplete="off" aria-label="quote lookup" class="input-text"> <input type="hidden" name="ss" value="fb"> <input type="submit" aria-label="submit" value="Search" class="input-search"></div></fieldset></form> </div></section><!----><div class="advert upper"><div class="ad-container desktop ad-w-300"> <div data-ad-pos="desktop" data-ad-size="300x600,300x250" class="ad gpt"></div> <span class="advert-txt">Advertisement</span></div><div class="ad-container tablet ad-w-300"> <div data-ad-pos="tablet" data-ad-size="300x250" class="ad gpt"></div> <span class="advert-txt">Advertisement</span></div><div class="ad-container mobile ad-w-300"> <div data-ad-pos="mobile" data-ad-size="300x250" class="ad gpt"></div> <span class="advert-txt">Advertisement</span></div></div><div class="embed-media advanced"><div class="item item-newsletter-article fox-business-rundown" data-slid="3DC725E303A24F8D5F8BE2343A002FB8">
        <div class="m logo">
            <img data-cke-saved-src="//static.foxnews.com/foxnews.com/content/uploads/2023/09/532x120-NEWSLETTER_BIZ-Rundown.png" src="//static.foxnews.com/foxnews.com/content/uploads/2023/09/532x120-NEWSLETTER_BIZ-Rundown.png" alt="Fox News First">
        </div>
        <div class="info">
            <div class="arrive">
                <span>Arrives Weekly</span>
            </div>
            <div class="newsletter-title">Get Our Newsletter</div>
            <p class="dek">Get a brief on the top business stories of the week, plus CEO interviews, market updates, tech and money news that matters to you.</p>
        <div class="user-input hide">
            <p class="success">We've added you to our mailing list.</p>
        </div>
            <div class="email-input">
                <input data-cke-saved-name="email" name="email" placeholder="Enter email address" type="email" class="input-email js-bound">
            </div>
            <div class="button subscribe">
                <a data-cke-saved-href="#" href="#">Subscribe</a>
            </div>
           <p class="disclosure">By clicking subscribe, you agree to the Fox News <a href="https://www.foxnews.com/privacy-policy" target="_blank">Privacy Policy</a> and <a href="https://www.foxnews.com/terms-of-use" target="_blank">Terms of Use</a>, and agree to receive content and promotional communications from Fox News. You understand that you can opt-out at any time.
           </p>
      </div>
</div>
</div> <div data-uid="SB_3" class="vendor-unit tablet-desktop"></div> <div data-uid="SB_5" class="vendor-unit tablet-desktop"></div></div></aside></div></article></main></div> <div class="post-content"></div></div> <footer data-fetch-key="3" class="site-footer"><div class="footer-upper"><div class="section-nav"><div class="inner"><nav aria-label="footer nav item 1 personal-finance" class="menu-personal-finance"><div class="nav-title"><a href="/personal-finance" data-omtr-intcmp="fbnnav1">Personal Finance</a></div> <ul class="submenu-personal-finance"><li class="nav-item menu-mortgages"><a href="/category/mortgage" data-omtr-intcmp="">Mortgages</a></li><li class="nav-item menu-student-loans"><a href="/category/student-loans" data-omtr-intcmp="">Student Loans</a></li><li class="nav-item menu-credit-cards"><a href="/category/credit-cards" data-omtr-intcmp="">Credit Cards</a></li><li class="nav-item menu-personal-loans"><a href="/category/personal-loans" data-omtr-intcmp="">Personal Loans</a></li><li class="nav-item menu-savings"><a href="/category/savings" data-omtr-intcmp="">Savings</a></li><li class="nav-item menu-insurance"><a href="/category/insurance" data-omtr-intcmp="">Insurance</a></li><li class="nav-item menu-401k"><a href="/category/401k" data-omtr-intcmp="">401k</a></li><li class="nav-item menu-retirement"><a href="/category/modern-retirement" data-omtr-intcmp="">Retirement</a></li><li class="nav-item menu-tax-planning"><a href="/category/tax-planning" data-omtr-intcmp="">Tax Planning</a></li><li class="nav-item menu-fox-money"><a href="/fox-money" data-omtr-intcmp="">FOX Money</a></li></ul></nav><nav aria-label="footer nav item 2 economy" class="menu-economy"><div class="nav-title"><a href="/economy" data-omtr-intcmp="">Economy</a></div> <ul class="submenu-economy"><li class="nav-item menu-government-spending"><a href="/category/government-spending" data-omtr-intcmp="">Government Spending</a></li><li class="nav-item menu-money-&amp;-policy"><a href="/category/money-and-policy" data-omtr-intcmp="">Money & Policy</a></li><li class="nav-item menu-small-business"><a href="/category/small-business" data-omtr-intcmp="">Small Business</a></li><li class="nav-item menu-inflation"><a href="/category/inflation" data-omtr-intcmp="">Inflation</a></li></ul></nav><nav aria-label="footer nav item 3 markets" class="menu-markets"><div class="nav-title"><a href="/markets" data-omtr-intcmp="">Markets</a></div> <ul class="submenu-markets"><li class="nav-item menu-stocks"><a href="/stocks" data-omtr-intcmp="">Stocks</a></li><li class="nav-item menu-us-markets"><a href="/category/us-markets" data-omtr-intcmp="">US Markets</a></li><li class="nav-item menu-cryptocurrency"><a href="/category/cryptocurrency" data-omtr-intcmp="">Cryptocurrency</a></li><li class="nav-item menu-futures-&amp;-commodities"><a href="/category/futures-commodities" data-omtr-intcmp="">Futures & Commodities</a></li><li class="nav-item menu-bonds"><a href="/category/bonds" data-omtr-intcmp="">Bonds</a></li><li class="nav-item menu-etfs"><a href="/category/etfs" data-omtr-intcmp="">ETFs</a></li><li class="nav-item menu-business-leaders"><a href="/category/business-leaders" data-omtr-intcmp="">Business Leaders</a></li><li class="nav-item menu-industries"><a href="/category/industries" data-omtr-intcmp="">Industries</a></li><li class="nav-item menu-retail"><a href="/category/retail" data-omtr-intcmp="">Retail</a></li><li class="nav-item menu-pre-markets"><a href="/category/pre-markets" data-omtr-intcmp="">Pre-Markets</a></li><li class="nav-item menu-mutual-funds"><a href="/category/mutual-funds" data-omtr-intcmp="">Mutual Funds</a></li></ul></nav><nav aria-label="footer nav item 4 watchlist" class="menu-watchlist"><div class="nav-title"><a href="/watchlist" data-omtr-intcmp="">Watchlist</a></div> <!----></nav><nav aria-label="footer nav item 5 lifestyle" class="menu-lifestyle"><div class="nav-title"><a href="/lifestyle" data-omtr-intcmp="">Lifestyle</a></div> <ul class="submenu-lifestyle"><li class="nav-item menu-entertainment"><a href="/category/entertainment" data-omtr-intcmp="">Entertainment</a></li><li class="nav-item menu-rich-&amp;-famous"><a href="/category/rich-famous" data-omtr-intcmp="">Rich & Famous</a></li><li class="nav-item menu-travel"><a href="/category/travel" data-omtr-intcmp="">Travel</a></li><li class="nav-item menu-cars"><a href="/category/cars" data-omtr-intcmp="">Cars</a></li><li class="nav-item menu-airplanes"><a href="/category/airplanes" data-omtr-intcmp="">Airplanes</a></li><li class="nav-item menu-food-&amp;-drinks"><a href="/category/food-drinks" data-omtr-intcmp="">Food & Drinks</a></li><li class="nav-item menu-arts"><a href="/category/arts" data-omtr-intcmp="">Arts</a></li></ul></nav><nav aria-label="footer nav item 6 real-estate" class="menu-real-estate"><div class="nav-title"><a href="/real-estate" data-omtr-intcmp="">Real Estate</a></div> <ul class="submenu-real-estate"><li class="nav-item menu-personal"><a href="/category/personal-real-estate" data-omtr-intcmp="">Personal</a></li><li class="nav-item menu-commercial"><a href="/category/commercial-real-estate" data-omtr-intcmp="">Commercial</a></li><li class="nav-item menu-luxury-properties"><a href="/category/luxury-properties" data-omtr-intcmp="">Luxury Properties</a></li></ul></nav><nav aria-label="footer nav item 7 tech" class="menu-tech"><div class="nav-title"><a href="/technology" data-omtr-intcmp="">Tech</a></div> <ul class="submenu-tech"><li class="nav-item menu-digital"><a href="/category/digital" data-omtr-intcmp="">Digital</a></li><li class="nav-item menu-social-media"><a href="/category/social-media" data-omtr-intcmp="">Social Media</a></li><li class="nav-item menu-gadgets"><a href="/category/gadgets" data-omtr-intcmp="">Gadgets</a></li><li class="nav-item menu-business-tech"><a href="/category/business-tech" data-omtr-intcmp="">Business Tech</a></li><li class="nav-item menu-healthcare-tech"><a href="/category/health-care-tech" data-omtr-intcmp="">Healthcare Tech</a></li><li class="nav-item menu-future-tech"><a href="/category/future-tech" data-omtr-intcmp="">Future Tech</a></li><li class="nav-item menu-ai"><a href="/category/artificial-intelligence" data-omtr-intcmp="">AI</a></li><li class="nav-item menu-space"><a href="/category/space-business" data-omtr-intcmp="">Space</a></li></ul></nav><nav aria-label="footer nav item 8 sports" class="menu-sports"><div class="nav-title"><a href="/sports" data-omtr-intcmp="">Sports</a></div> <ul class="submenu-sports"><li class="nav-item menu-nfl"><a href="/category/nfl" data-omtr-intcmp="">NFL</a></li><li class="nav-item menu-nba"><a href="/category/nba" data-omtr-intcmp="">NBA</a></li><li class="nav-item menu-mlb"><a href="/category/mlb" data-omtr-intcmp="">MLB</a></li><li class="nav-item menu-nascar"><a href="/category/nascar" data-omtr-intcmp="">NASCAR</a></li><li class="nav-item menu-boxing"><a href="/category/boxing" data-omtr-intcmp="">Boxing</a></li><li class="nav-item menu-soccer"><a href="/category/soccer" data-omtr-intcmp="">Soccer</a></li><li class="nav-item menu-golf"><a href="/category/golf" data-omtr-intcmp="">Golf</a></li><li class="nav-item menu-tennis"><a href="/category/tennis" data-omtr-intcmp="">Tennis</a></li></ul></nav><nav aria-label="footer nav item 9 opinion" class="menu-opinion"><div class="nav-title"><a href="/opinion" data-omtr-intcmp="">Opinion</a></div> <!----></nav><nav aria-label="footer nav item 10 video" class="menu-video"><div class="nav-title"><a href="/video" data-omtr-intcmp="">Video</a></div> <!----></nav><nav aria-label="footer nav item 11 about" class="menu-about"><div class="nav-title"><a href="/about-us" data-omtr-intcmp="">About</a></div> <ul class="submenu-about"><li class="nav-item menu-channel-finder"><a href="/channel-finder" data-omtr-intcmp="">Channel Finder</a></li><li class="nav-item menu-jobs"><a href="https://www.foxcareers.com/" data-omtr-intcmp="">Jobs</a></li><li class="nav-item menu-terms-of-use"><a href="/terms-of-use" data-omtr-intcmp="">Terms of Use</a></li><li class="nav-item menu-updated-privacy-policy"><a href="/privacy-policy" data-omtr-intcmp="">Updated Privacy Policy</a></li><li class="nav-item menu-faq"><a href="https://help.foxbusiness.com/hc/en-us/sections/4405278462107-FAQ" data-omtr-intcmp="">FAQ</a></li><li class="nav-item menu-media-relations"><a href="https://press.foxbusiness.com/media-contacts/" data-omtr-intcmp="">Media Relations</a></li><li class="nav-item menu-corporate-information"><a href="https://press.foxbusiness.com" data-omtr-intcmp="">Corporate Information</a></li><li class="nav-item menu-closed-captioning-policy"><a href="/closed-captioning" data-omtr-intcmp="">Closed Captioning Policy</a></li><li class="nav-item menu-accessibility-statement"><a href="/accessibility-statement" data-omtr-intcmp="">Accessibility Statement</a></li><li class="nav-item menu-fox-news"><a href="https://www.foxnews.com/" data-omtr-intcmp="">Fox News</a></li><li class="nav-item menu-fox-nation"><a href="https://nation.foxnews.com/" data-omtr-intcmp="">Fox Nation</a></li><li class="nav-item menu-fox-business-go"><a href="https://www.foxbusiness.com/video/5640669329001" data-omtr-intcmp="">Fox Business Go</a></li><li class="nav-item menu-apps-&amp;-products"><a href="/apps-products" data-omtr-intcmp="">Apps & Products</a></li></ul></nav></div></div></div> <div class="footer-lower"><div class="social-icons"><ul><li class="fb"><a href="http://www.facebook.com/FoxBusiness">Facebook</a></li> <li class="tw"><a href="http://twitter.com/foxbusiness">Twitter</a></li> <li class="rss"><a href="https://www.foxbusiness.com/fox-business-rss-feed">RSS</a></li></ul></div> <div class="branding"><a href="/" class="logo">Fox Business</a></div> <div class="legal"><ul data-fetch-key="4"><li><a href="/terms-of-use" data-omtr-intcmp="footer_termsofuse">New Terms of Use</a></li><li><a href="/privacy-policy" data-omtr-intcmp="footer_privacypolicy">New Privacy Policy</a></li><li><a href="https://privacy.foxbusiness.com/main/web/main" data-omtr-intcmp="footer_privacychoices">Your Privacy Choices</a></li><li><a href="https://help.foxbusiness.com/hc/en-us" data-omtr-intcmp="footer_help">Help</a></li><li><a href="/closed-captioning/" data-omtr-intcmp="footer_closedcaptioning">Closed Captioning Policy</a></li></ul> <div class="policy"><p>
            Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by <a href="https://www.factset.com/">Factset</a>.
            Powered and implemented by <a href="https://www.factset.com/solutions/business-needs/digital-solutions">FactSet Digital Solutions</a>. 
            <a href="https://www.factset.com/privacy">Legal Statement</a>.
        </p> <p>This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. <a href="https://help.foxbusiness.com/hc/en-us/sections/4405278462107-FAQ">FAQ</a> - <a href="/privacy-policy">New Privacy Policy</a></p></div></div></div></footer> <noscript>
        <img src="https://smetrics.foxbusiness.com/b/ss/%OMNITURE_ACCOUNT_ID%/1/H22.1--NS/1518822074763?pageName=fox-news-health:subsection:article&g=https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug" style="display:none;" width="0" height="0" border="0" alt="">
        <img src="https://secure-us.imrworldwide.com/cgi-bin/m?ci=us-201978h&amp;cg=0&amp;cc=1&amp;si=https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug&amp;ts=noscript&amp;rnd=1518822074763" style="display:none;" width="0" height="0" border="0" alt="">
        <img src="https://sb.scorecardresearch.com/p?c1=2&c2=9013181&c3=&c4=https://www.foxbusiness.com/fox-news-health/wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug&c5=&c6=&c15=&cv=2.2&cj=1" style="display:none;" width="0" height="0" border="0" alt="">
      </noscript></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH,aI,aJ,aK,aL,aM,aN,aO,aP,aQ,aR,aS,aT,aU,aV,aW,aX,aY,aZ,a_,a$,ba,bb,bc,bd,be,bf,bg,bh,bi,bj,bk,bl,bm,bn,bo,bp,bq,br,bs,bt,bu,bv,bw,bx,by,bz,bA,bB,bC,bD,bE,bF,bG,bH,bI,bJ,bK,bL,bM,bN,bO,bP,bQ,bR,bS,bT,bU,bV,bW,bX,bY,bZ,b_,b$,ca,cb,cc,cd,ce,cf,cg,ch,ci,cj,ck,cl,cm,cn,co,cp,cq,cr,cs,ct,cu,cv,cw,cx,cy,cz,cA,cB,cC,cD,cE,cF,cG,cH,cI,cJ,cK,cL,cM,cN,cO,cP,cQ,cR,cS,cT,cU,cV,cW,cX,cY,cZ,c_,c$,da,db,dc,dd,de,df,dg,dh,di,dj,dk,dl,dm,dn,do0,dp,dq,dr,ds,dt,du,dv,dw,dx,dy,dz,dA,dB,dC,dD,dE,dF,dG,dH,dI,dJ,dK,dL,dM,dN,dO,dP,dQ,dR,dS,dT,dU,dV,dW,dX,dY,dZ,d_,d$,ea,eb,ec,ed,ee,ef,eg,eh,ei,ej,ek,el,em,en,eo,ep,eq,er,es,et,eu,ev,ew,ex,ey,ez,eA,eB,eC,eD,eE,eF,eG,eH,eI,eJ,eK,eL,eM,eN,eO,eP,eQ,eR,eS,eT,eU,eV,eW,eX,eY,eZ,e_,e$,fa,fb,fc,fd,fe,ff,fg,fh,fi,fj,fk,fl,fm,fn,fo,fp,fq,fr,fs,ft,fu,fv,fw,fx,fy,fz,fA,fB,fC,fD,fE,fF,fG,fH,fI,fJ,fK,fL,fM,fN,fO,fP,fQ,fR,fS,fT,fU,fV,fW,fX,fY,fZ,f_){eb[0]={uuidv5:ac,fn__type:j,person_id:ad,name_id:ae,canonical_url:v,page_url:v,first_name:af,last_name:ag,full_name:t,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:t,blog_urls:[],full_bio_url:a,company_name:a,short_bio:ah};ei.name=e;ei.url=g;en[0]={is:"bright-cove",props:{id:eo,thumbnail:av,title:ep,description:ct,url:"http:\u002F\u002Fvideo.foxbusiness.com\u002Fv\u002F6347778473112",domain:"foxbusiness"}};en[1]={is:d,props:{parsedParagraph:"Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday."}};en[2]={is:d,props:{parsedParagraph:"The injectable semaglutide &#x2014; originally approved for \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fnutrition-and-fitness\u002Fweight-loss\"\u003E\u003Cu\u003Eweight loss\u003C\u002Fu\u003E\u003C\u002Fa\u003E for certain patients &#x2014; is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either overweight or obese, the announcement stated.&#xA0;"}};en[3]={is:d,props:{parsedParagraph:"&quot;Wegovy is now the first \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fhealthy-living\u002Fmedications\"\u003E\u003Cu\u003Eweight-loss medication\u003C\u002Fu\u003E\u003C\u002Fa\u003E to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,&quot; said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA&#x2019;s Center for Drug Evaluation and Research, in the press release.&#xA0;"}};en[4]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Flifestyle\u002Fceos-ask-wegovys-novo-nordisk-for-advice-after-shift-in-trends\"\u003E\u003Cstrong\u003E\u003Cu\u003ENOVO NORDISK CEO SAYS FOOD EXECS ARE &#x2018;SCARED&#x2019; OF WEIGHT-LOSS DRUG THREAT\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[5]={is:d,props:{parsedParagraph:"&quot;This patient population has a higher risk of cardiovascular death, heart attack and stroke,&quot; he also said.&#xA0;"}};en[6]={is:d,props:{parsedParagraph:"&quot;Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fhealth\"\u003E\u003Cu\u003Epublic health\u003C\u002Fu\u003E\u003C\u002Fa\u003E.&quot;&#xA0;"}};en[7]={is:cu,props:{url:u,externalUrl:a,imageAlt:T,description:"Novo Nordisk's blockbuster obesity medicine, Wegovy, reduced the risk of heart attacks and strokes in a highly anticipated study.",shortDescription:a,copyright:aa,source:U,alignment:cv}};en[8]={is:d,props:{parsedParagraph:"Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated."}};en[9]={is:d,props:{parsedParagraph:"The approval comes after a large, randomized, double-blind trial that included 17,600 participants in two groups."}};en[10]={is:d,props:{parsedParagraph:"Both groups received &quot;standard-of-care medical treatment (e.g., management of blood pressure and cholesterol) and healthy lifestyle counseling (including diet and physical activity).&quot;"}};en[11]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Flifestyle\u002Fdiabetes-related-weight-loss-drugs-supply-issues-viral-trend\"\u003E\u003Cstrong\u003E\u003Cu\u003EDIABETES-RELATED WEIGHT-LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[12]={is:d,props:{parsedParagraph:"In the trial, the group that took Wegovy showed a significant reduction in cardiovascular death, \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fnervous-system-health\u002Fstroke\"\u003E\u003Cu\u003Eheart attack and stroke\u003C\u002Fu\u003E\u003C\u002Fa\u003E."}};en[13]={is:d,props:{parsedParagraph:"Brooke Boyarsky Pratt, the CEO of knownwell, a Boston-based weight management company, said the announcement marked &quot;an exciting day&quot; for patients with \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fheart-health\"\u003E\u003Cu\u003Eheart disease\u003C\u002Fu\u003E\u003C\u002Fa\u003E as well as their doctors."}};en[14]={is:d,props:{parsedParagraph:"&quot;This approval is an important step in getting patients access to potentially life-saving medication,&quot; Pratt said in a statement to Fox News Digital."}};en[15]={is:cu,props:{url:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2023\u002F08\u002FWegovy-2.jpg",externalUrl:a,imageAlt:T,description:"The injectable semaglutide Wegovy was originally approved for weight loss for eligible patients.",shortDescription:a,copyright:"Steffen Trumpf\u002Fpicture alliance via Getty Images",source:U,alignment:cv}};en[16]={is:d,props:{parsedParagraph:"&quot;It continues to support what the medical community has known all along &#x2014; GLP-1s are here to treat serious chronic diseases, now cardiovascular disease in addition to diabetes and obesity.&quot;"}};en[17]={is:d,props:{parsedParagraph:"The FDA&#x2019;s approval is a step in the right direction toward battling the &quot;bias and stigma&quot; around these medications, she said."}};en[18]={is:d,props:{parsedParagraph:"&quot;Significantly reducing the risk of cardiac disease in patients who are at a higher risk is incredibly important to both patients and clinicians,&quot; Pratt went on.&#xA0;"}};en[19]={is:"quote",props:{text:"This is a \"landmark decision in the field of medical therapy for obesity.\"",credit:a}};en[20]={is:d,props:{parsedParagraph:"&quot;We hope that with this indication, these patients who unfortunately may not have had coverage for these medications before will soon find them covered.&quot;"}};en[21]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Flifestyle\u002Fweight-loss-medication-shortage-creates-market-bogus-drugs\"\u003E\u003Cstrong\u003E\u003Cu\u003EWEIGHT-LOSS MEDICATION SHORTAGE CREATES MARKET FOR BOGUS DRUGS\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[22]={is:d,props:{parsedParagraph:"Dr. Darren McGuire, a cardiologist at UT Southwestern in Dallas, Texas, called the FDA&#x2019;s approval a &quot;landmark decision in the field of medical therapy for obesity.&quot;"}};en[23]={is:d,props:{parsedParagraph:"He told Fox News Digital, &quot;With this FDA action, semaglutide becomes the first medication ever in the U.S. approved for the treatment of persons \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fnutrition-and-fitness\u002Fobesity\"\u003E\u003Cu\u003Eliving with obesity\u003C\u002Fu\u003E\u003C\u002Fa\u003E with anything beyond a claim of cardiovascular safety.&quot;"}};en[24]={is:cu,props:{url:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2023\u002F10\u002FNovo-Nordisk.jpg",externalUrl:a,imageAlt:"Novo Nordisk headquarters",description:"A general view of the headquarters of Danish pharmaceutical company Novo Nordisk in Copenhagen, Denmark, on Sept. 26, 2023.",shortDescription:a,copyright:"REUTERS\u002FTom Little\u002FFile photo",source:"Reuters Photos",alignment:cv}};en[25]={is:d,props:{parsedParagraph:"The decision, McGuire said, reinforces what most medical experts have known for decades &#x2014; &quot;that reducing body weight for persons living with obesity would reduce risk for a broad spectrum of obesity-related complications, cardiovascular and otherwise.&quot;&#xA0;"}};en[26]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Fapps-products\"\u003E\u003Cstrong\u003E\u003Cu\u003EGET FOX BUSINESS ON THE GO BY CLICKING HERE\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[27]={is:d,props:{parsedParagraph:"McGuire, who is an expert in heart disease and prevention, especially among \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fhealth\u002Fdiabetes\"\u003E\u003Cu\u003Epeople with diabetes\u003C\u002Fu\u003E\u003C\u002Fa\u003E, predicts that approximately one in five U.S. adults would benefit from treatment with semaglutide."}};en[28]={is:d,props:{parsedParagraph:"&quot;Conservatively, around 55 million U.S. adults have an indication for cardiovascular risk reduction with semaglutide,&quot; he said."}};en[29]={is:d,props:{parsedParagraph:"Looking ahead, McGuire predicts that many similar medications will enter the market in years to come."}};en[30]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Fmedia\u002Ffda-chief-sounds-alarm-over-fake-weight-loss-drugs-circulating-online\"\u003E\u003Cstrong\u003E\u003Cu\u003EFDA CHIEF SOUNDS ALARM OVER SALE OF FAKE WEIGHT-LOSS DRUGS CIRCULATING ONLINE\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[31]={is:d,props:{parsedParagraph:"&quot;Presently, semaglutide is only one drug in one class with proof of cardiovascular efficacy and with FDA approval for such,&quot; he told Fox News Digital. &quot;Many more medications are presently being developed and tested similarly, so this field will rapidly evolve.&quot;"}};en[32]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fnewsletters?cmpid=fnfirstnl\"\u003E\u003Cstrong\u003E\u003Cu\u003ECLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fa\u003E"}};en[33]={is:d,props:{parsedParagraph:"Patients should speak with a health care provider about the potential benefits and side effects of Wegovy, experts say."}};en[34]={is:d,props:{parsedParagraph:"Fox News Digital reached out to Novo Nordisk requesting additional comment."}};en[35]={is:d,props:{parsedParagraph:"\u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fhealth\"\u003E\u003Ci\u003E\u003Cstrong\u003E\u003Cu\u003EFor more Health articles, visit \u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fi\u003E\u003C\u002Fa\u003E\u003Ca href=\"http:\u002F\u002Fwww.foxnews\u002Fhealth\"\u003E\u003Ci\u003E\u003Cstrong\u003E\u003Cu\u003Ewww.foxnews.com\u002Fhealth\u003C\u002Fu\u003E\u003C\u002Fstrong\u003E\u003C\u002Fi\u003E\u003C\u002Fa\u003E\u003Ci\u003E\u003Cstrong\u003E.\u003C\u002Fstrong\u003E\u003C\u002Fi\u003E"}};fZ.model=[{subsections:[{name:az,tracking:a,url:aA},{name:aB,tracking:a,url:aC},{name:aD,tracking:a,url:aE},{name:aF,tracking:a,url:aG},{name:aH,tracking:a,url:aI},{name:aJ,tracking:a,url:aK},{name:aL,tracking:a,url:aM},{name:c_,tracking:a,url:aN},{name:aO,tracking:a,url:aP}],name:aQ,tracking:a,url:aR},{subsections:[{name:aS,tracking:a,url:aT},{name:c$,tracking:a,url:aU},{name:R,tracking:a,url:aV},{name:da,tracking:a,url:db}],name:F,tracking:a,url:G},{subsections:[{name:aW,tracking:a,url:dc},{name:aX,tracking:a,url:aY},{name:aZ,tracking:a,url:a_},{name:dd,tracking:a,url:a$},{name:ba,tracking:a,url:bb},{name:bc,tracking:a,url:bd},{name:be,tracking:a,url:bf},{name:bg,tracking:a,url:bh},{name:y,tracking:a,url:bi},{name:de,tracking:a,url:bj},{name:bk,tracking:a,url:bl}],name:x,tracking:a,url:bm},{subsections:[],name:bn,tracking:a,url:bo},{subsections:[{name:bp,tracking:a,url:bq},{name:df,tracking:a,url:br},{name:bs,tracking:a,url:bt},{name:bu,tracking:a,url:bv},{name:bw,tracking:a,url:bx},{name:dg,tracking:a,url:H},{name:by,tracking:a,url:bz}],name:i,tracking:a,url:bA},{subsections:[{name:dh,tracking:a,url:bB},{name:di,tracking:a,url:bC},{name:bD,tracking:a,url:bE}],name:bF,tracking:a,url:bG},{subsections:[{name:bH,tracking:a,url:bI},{name:bJ,tracking:a,url:bK},{name:bL,tracking:a,url:bM},{name:bN,tracking:a,url:bO},{name:bP,tracking:a,url:bQ},{name:bR,tracking:a,url:bS},{name:bT,tracking:a,url:L},{name:bU,tracking:a,url:dj}],name:Y,tracking:a,url:Q},{subsections:[{name:dk,tracking:a,url:dl},{name:dm,tracking:a,url:dn},{name:do0,tracking:a,url:dp},{name:dq,tracking:a,url:dr},{name:ds,tracking:a,url:dt},{name:du,tracking:a,url:dv},{name:dw,tracking:a,url:dx},{name:dy,tracking:a,url:dz}],name:dA,tracking:a,url:dB},{subsections:[],name:dC,tracking:a,url:dD},{subsections:[],name:bV,tracking:a,url:bW},{subsections:[{name:dE,tracking:a,url:dF},{name:K,tracking:a,url:dG},{name:dH,tracking:a,url:Z},{name:dI,tracking:a,url:_},{name:dJ,tracking:a,url:dK},{name:dL,tracking:a,url:dM},{name:dN,tracking:a,url:dO},{name:$,tracking:a,url:dP},{name:dQ,tracking:a,url:dR},{name:dS,tracking:a,url:dT},{name:dU,tracking:a,url:dV},{name:dW,tracking:a,url:dX},{name:dY,tracking:a,url:dZ}],name:d_,tracking:a,url:d$}];f_.model={bannerType:"blank",headline:a,url:a};return {layout:f,data:[{layout:{main:[],rightRail:[{is:"stocks",props:{stocks:b}},{is:ea,props:{ads:[],classNames:"ad-container large desktop"}},{is:ea,props:{ads:[{id:b,device:"desktop",sizes:["300x600",bX],showAdvertText:h},{id:b,device:"tablet",sizes:[bX],showAdvertText:h},{id:b,device:"mobile",sizes:[bX],showAdvertText:h}],classNames:"advert upper"}},{is:"advanced-media",props:{content:"\u003Cdiv class=\"item item-newsletter-article fox-business-rundown\" data-slid=\"3DC725E303A24F8D5F8BE2343A002FB8\"\u003E\n        \u003Cdiv class=\"m logo\"\u003E\n            \u003Cimg data-cke-saved-src=\"\u002F\u002Fstatic.foxnews.com\u002Ffoxnews.com\u002Fcontent\u002Fuploads\u002F2023\u002F09\u002F532x120-NEWSLETTER_BIZ-Rundown.png\" src=\"\u002F\u002Fstatic.foxnews.com\u002Ffoxnews.com\u002Fcontent\u002Fuploads\u002F2023\u002F09\u002F532x120-NEWSLETTER_BIZ-Rundown.png\" alt=\"Fox News First\"\u003E\n        \u003C\u002Fdiv\u003E\n        \u003Cdiv class=\"info\"\u003E\n            \u003Cdiv class=\"arrive\"\u003E\n                \u003Cspan\u003EArrives Weekly\u003C\u002Fspan\u003E\n            \u003C\u002Fdiv\u003E\n            \u003Cdiv class=\"newsletter-title\"\u003EGet Our Newsletter\u003C\u002Fdiv\u003E\n            \u003Cp class=\"dek\"\u003EGet a brief on the top business stories of the week, plus CEO interviews, market updates, tech and money news that matters to you.\u003C\u002Fp\u003E\n        \u003Cdiv class=\"user-input hide\"\u003E\n            \u003Cp class=\"success\"\u003EWe've added you to our mailing list.\u003C\u002Fp\u003E\n        \u003C\u002Fdiv\u003E\n            \u003Cdiv class=\"email-input\"\u003E\n                \u003Cinput data-cke-saved-name=\"email\" name=\"email\" placeholder=\"Enter email address\" type=\"email\" class=\"input-email js-bound\"\u003E\n            \u003C\u002Fdiv\u003E\n            \u003Cdiv class=\"button subscribe\"\u003E\n                \u003Ca data-cke-saved-href=\"#\" href=\"#\"\u003ESubscribe\u003C\u002Fa\u003E\n            \u003C\u002Fdiv\u003E\n           \u003Cp class=\"disclosure\"\u003EBy clicking subscribe, you agree to the Fox News \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fprivacy-policy\" target=\"_blank\"\u003EPrivacy Policy\u003C\u002Fa\u003E and \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fterms-of-use\" target=\"_blank\"\u003ETerms of Use\u003C\u002Fa\u003E, and agree to receive content and promotional communications from Fox News. You understand that you can opt-out at any time.\n           \u003C\u002Fp\u003E\n      \u003C\u002Fdiv\u003E\n\u003C\u002Fdiv\u003E\n"}}],preContent:[]},fullArticle:{meta_description:S,meta_title:a,fn__distribution_platforms:{google_news:{amp:h,live_coverage:h,standout:h},android:{enabled:h},apple_news:{enabled:h,notification_dates:[],enabled_date:"2024-03-09T18:05:50Z"},automated_alerts:{enabled:c},facebook_news:{suppress:c,opinion:c},facebook_instant_articles:{enabled:c},ios:{enabled:h},search_engines:{enabled:h},distribution_true_anthem:{enabled:c},distribution_yahoo:{enabled:c},distribution_msn:{enabled:c},distribution_smart_news:{enabled:c},distribution_flipboard:{enabled:c},distribution_snapchat:{enabled:c},distribution_newsbreak:{enabled:c},wire_override:c,web:{enabled:h}},distribution_site_search:h,thumbnail:{content:{alt:T,caption:bY,url:u,wp__origin:{post_id:bZ,blog_id:n,environment:p,post_type:I,site:q,source:r},copyright:aa,source:{uuidv5:b_,label:U,url:b$,canonical_url:ca,wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:cb,post_type:ab}}},content_type:z,uuidv5:cc,url:u},fn__image:{content:{alt:T,caption:bY,url:u,wp__origin:{post_id:bZ,blog_id:n,environment:p,post_type:I,site:q,source:r},copyright:aa,source:{uuidv5:b_,label:U,url:b$,canonical_url:ca,wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:cb,post_type:ab}}},content_type:z,uuidv5:cc,url:u},social_image:{content:{alt:T,caption:bY,url:u,wp__origin:{post_id:bZ,blog_id:n,environment:p,post_type:I,site:q,source:r},copyright:aa,source:{uuidv5:b_,label:U,url:b$,canonical_url:ca,wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:cb,post_type:ab}}},content_type:z,uuidv5:cc,url:u},fox_bet:c,full_span_image:s,livefyre__:{storify:c},local_tags:[],pill:a,prevent_gating:c,fn__contributors:eb,share:[],shared_category:[],wp__shared_category:s,shared_tags:[],wp__shared_tags:[],short_title:k,show_advertisements:c,spark_persons:[],spark_shows:[],starts_with_dropcap:c,spotim:{event_code:a,id:a},stock_tickers:"[\"NVO\"]",storycard_description:a,storycard_image:s,storycard_image_format:a,storycard_tag:[],storycard_title:k,sync_description:c,sync_image:c,branding:{fn__disclaimer:a,fn__indicator:a,fn__campaign_id:a,fn__sponsor_logo:s,fn__sponsor_name:a,advertorial:c},fn__breaking_news:c,fn__sections:[{uuidv5:cd,path:ce,isa_value:a}],wp__category:{title:e,slug:w,uuidv5:cd,path:ce,isa_value:a},fn__shows:[],comments:{enabled:h},foxid:{enabled:c},dateline:a,dek:S,fn__section_description:a,social_description:a,fn__external_feeds_title:k,fn__featured:c,fn__footer:a,fn__app_title:k,fn__apple_news_title:k,export_headline:a,fn__fbia_title:k,fn__section_title:k,social_title:k,slug:cf,fn__sources:[{uuidv5:"f1fef71e-f80f-56d1-83bd-dbdae1b8fc0b",fn__type:"sources",label:cg,slug:"foxbusiness-4",url:ch,canonical_url:"foxbusiness.com\u002Fsource\u002Ffoxbusiness-4",wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:734246,post_type:ab}}],standfirst:ci,fn__tags:[{spark_id:ai,uuidv5:ai,title:e,slug:w,path:aj,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:ak,uuidv5:ak,title:V,slug:ec,path:cj,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:al,uuidv5:al,title:W,slug:ed,path:ck,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:am,uuidv5:am,title:an,slug:ee,path:cl,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:ao,uuidv5:ao,title:ap,slug:ef,path:cm,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:aq,uuidv5:aq,title:i,slug:ar,path:cn,isa_value:ar,type:eg,tag_type:A,external_uri:a,external_id:a},{spark_id:as,uuidv5:as,title:B,slug:eh,path:co,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a}],wp__tags:[{spark_id:ai,uuidv5:ai,title:e,slug:w,path:aj,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:ak,uuidv5:ak,title:V,slug:ec,path:cj,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:al,uuidv5:al,title:W,slug:ed,path:ck,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:am,uuidv5:am,title:an,slug:ee,path:cl,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:ao,uuidv5:ao,title:ap,slug:ef,path:cm,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a},{spark_id:aq,uuidv5:aq,title:i,slug:ar,path:cn,isa_value:ar,type:eg,tag_type:A,external_uri:a,external_id:a},{spark_id:as,uuidv5:as,title:B,slug:eh,path:co,isa_value:a,type:a,tag_type:a,external_uri:a,external_id:a}],tags:[ei,{name:V,url:cp},{name:W,url:cq},{name:an,url:ej},{name:ap,url:ek},{name:i,url:m},{name:B,url:J}],fn__legacy_type:f,fn__story_type:cr,third_party_canonical_url:a,origination_station:"FB",original_post_canonical_url:a,fn__additional_authors:[],shared_shows:[],vanity_urls:[],short_urls:[a],original_post:{original_post_id:a,original_post_uuidv5:a,original_post_share:a,original_external_post_type:a},urls:{url:cs,category:{slug:w,spark_id:cd},slug:cf,original_publisher:a,original_url:a,original_publish_date:a},id:at,spark_id:at,uuidv5:at,fn__type:el,last_modified_date:au,last_published_date:C,created_date:em,publication_date:C,origination_modified_date:au,wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:2402476,post_type:"post",post_status:D},post_status:D,published:h,articleId:a,components:en,title:k,canonical_url:cs,article_slug:cf,vanity_slugs:[],presentation_type:f,fn__syndication_info:[],fn__stock_ticker_symbols:a,post_version:1051648,component_type:"news_article",content_type:"spark_post",fn__site_search:h,stocks:[{spark_id:eq,id:eq,external_id:o,external_uri:"US:NVO",external_stock_symbol:er,title:es,type:et,tag_type:et,label:es,description:a,slug:"us-nvo",created_date:cw,original_import_date:cw,last_import_date:cw,page_url:eu,canonical_url:eu,post_status:D,path:"fox-business\u002Fstocks\u002Fus-nvo"}],meta:{chartbeat:{title:k,viewID:cx,section:w,authors:[t]},segment:{title:k,page_content_type:el,page_content_type_of_story:cr}},isAMP:c,isPreview:c,overlayType:f,storyType:cr,section:w,header:{headline:k,standfirst:ci,authors:[{name:t,url:"https:\u002F\u002Fwww.foxbusiness.com\u002Fperson\u002Fr\u002Fmelissa-rudy"}],publicationDate:C,modificationDate:C,category:ei,organizationName:cg,organizationUrl:"https:\u002F\u002Fwww.foxbusiness.com\u002F",headerCategory:{name:e,url:aj}},headlines:{socialMedia:k,socialDescription:a,section:k,appleNews:k,FBIA:k,app:k,exportHeadline:k}},articleMeta:{id:at,title:k,description:S,metaTitle:a,metaDescription:S,standfirst:ci,section:w,subsection:w,articleURL:"https:\u002F\u002Fwww.foxbusiness.com\u002Ffox-news-health\u002Fwegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug",image:u,tags:[aj,cj,ck,cl,cm,cn,co],articleSection:ce,source:cg,sourceUrl:ch,createdDate:em,modifiedDate:au,publishedDate:C,lastModifiedDate:au,lastPublishedDate:C,authorName:t,authors:eb,canonicalUrl:cs,shorturl:a,social:{title:k,description:a,image:u},isOpinion:c,articleBody:en},spotIM:b,ampCSS:a}],fetch:[{isMounted:c,omnitureAccount:"%OMNITURE_ACCOUNT_ID%",videoData:{id:ev,autoplay:c,component_type:"video",content_topic:a,content_type:"external_brightcove_clip",spark_id:ev,external_id:eo,thumbnail:{alt:a,caption:a,copyright:a,url:av,content_type:z,spark_id:a},title:ep,description:ct,long_description:ct,last_modified_date:ew,last_published_date:ew,post_status:D,source:{url:a,spark_id:a,fn__type:a,slug:a,label:ex},spark_shows:{description:"Host Charles Payne gives viewers an end-of-day wrap, and provide an insider's look at tomorrow's money makers.",fn__airtime:"Weekdays at 2:00 pm",episodes_playlist_id:ey,meta_description:a,meta_title:a,clips_playlist_id:ey,youtube:a,instagram:a,airtime:a,facebook_url:"https:\u002F\u002Fwww.facebook.com\u002FCharlesPayneFox",twitter_username:"cvpayne",email:"MakingMoneyCharlesPayne@foxbusiness.com",podcast_url:a,spotify:a,apple_podcast_url:a,fn__tags:[],wp__tags:[],tags:[],media_tags:[ez],sort_order:"5",fn__hosts:[{uuidv5:"ce2ccabe-d870-5d03-9072-4b9188a3ee78",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fp\u002Fcharles-payne",name_id:"charles-payne",canonical_url:eA,page_url:eA,first_name:"Charles",last_name:"Payne",full_name:cy,middle_initial:a,personality_name:a,prefix:a,role:"Personality",job_title:a,title:cy,blog_urls:[],full_bio_url:"https:\u002F\u002Fwww.foxbusiness.com\u002Fperson\u002Fp\u002Fcharles-payne.html",company_name:a,short_bio:"\u003Cp\u003ECharles Payne is the host of \u003Ci\u003EMaking Money with Charles Payne\u003C\u002Fi\u003E (weekdays 2-3PM\u002FET) and joined FOX Business Network (FBN) in October 2007 as a contributor. He is also a contributor to FOX News Channel.\u003C\u002Fp\u003E"}],tagboard_id:a,image:{content:{alt:a,caption:a,url:eB,wp__origin:{post_id:2397896,blog_id:n,environment:p,post_type:I,site:q,source:r}},content_type:z,uuidv5:"a6d817e2-4cf0-5331-806c-ddfb63dd02d3",url:eB},mobile_poster_image:{content:{alt:a,caption:a,url:eC,wp__origin:{post_id:2397897,blog_id:n,environment:p,post_type:I,site:q,source:r}},content_type:z,uuidv5:"5fe59fff-203d-5ee1-b69d-919c4a4f311e",url:eC},mobile_banner_image:{content:{alt:a,caption:a,url:eD,wp__origin:{post_id:2397898,blog_id:n,environment:p,post_type:I,site:q,source:r}},content_type:z,uuidv5:"57289903-23fd-5f40-bd77-79704202a3b3",url:eD},show_top_parallax:{headshot_image:s,logo_image:s,background_image:s},delta_show_code:a,gracenote_id:a,foxipedia_id:a,colors:{primary:a},relevance:a,vanity_urls:["shows\u002Fmaking-money.html"],airtime_days:{weekdays:{start:a,end:a},monday:{start:a,end:a},tuesday:{start:a,end:a},wednesday:{start:a,end:a},thursday:{start:a,end:a},friday:{start:a,end:a},saturday:{start:a,end:a},sunday:{start:a,end:a}},canonical_url:"foxbusiness.com\u002Fshows\u002Fmaking-money-with-charles-payne",id:cz,spark_id:cz,uuidv5:cz,fn__type:cA,last_modified_date:eE,last_published_date:eF,created_date:"2014-12-29T13:41:35-05:00",publication_date:eF,origination_station:a,origination_modified_date:eE,wp__origin:{source:r,site:q,environment:p,blog_id:n,post_id:520881,post_type:eG,post_status:D},post_status:D,published:h,title:X,vanity_slugs:["making-money.html"],show_slug:eH,meta:{chartbeat:{title:X,viewID:"shows\u002Fmaking-money-with-charles-payne",authors:[cy]},segment:{title:X,page_content_type:cA,page_content_type_of_story:eG}}},external_source:ex,canonical_url:eI,vanity_urls:[eI],playback_url:a,brightcove:{domain:ch,duration:"0:05:34",end_date:a,streams:[{url:"http:\u002F\u002Fmanifest.prod.boltdns.net\u002Fmanifest\u002Fv1\u002Fhls\u002Fv4\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F10s\u002Fmaster.m3u8?fastly_token=NjZkNDYwNmNfOTdiN2RlMzdjZDY3MmEyYTRmMjkxMWZjY2M5NmUxZGMxOTA5OTBiMWFiNzc0ZGNjNDk4ZjIzNmYwMDMyMzdjYw%3D%3D",mime_type:a,width:o,height:o,file_size:o},{url:"https:\u002F\u002Fmanifest.prod.boltdns.net\u002Fmanifest\u002Fv1\u002Fhls\u002Fv4\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F10s\u002Fmaster.m3u8?fastly_token=NjZkNDYwNmNfOTdiN2RlMzdjZDY3MmEyYTRmMjkxMWZjY2M5NmUxZGMxOTA5OTBiMWFiNzc0ZGNjNDk4ZjIzNmYwMDMyMzdjYw%3D%3D",mime_type:a,width:o,height:o,file_size:o},{url:"http:\u002F\u002Fmanifest.prod.boltdns.net\u002Fmanifest\u002Fv1\u002Fdash\u002Flive-baseurl\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F6s\u002Fmanifest.mpd?fastly_token=NjZkNDYwNmNfODgzOGNkYWE5NWFkYzllY2UwZWYzZjliMWZiZjIzOGE5YzcyOWZjNzA3NDdmMzI5NDAwYzhkNTM2ZmU4MjQxYg%3D%3D",mime_type:a,width:o,height:o,file_size:o},{url:"https:\u002F\u002Fmanifest.prod.boltdns.net\u002Fmanifest\u002Fv1\u002Fdash\u002Flive-baseurl\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F6s\u002Fmanifest.mpd?fastly_token=NjZkNDYwNmNfODgzOGNkYWE5NWFkYzllY2UwZWYzZjliMWZiZjIzOGE5YzcyOWZjNzA3NDdmMzI5NDAwYzhkNTM2ZmU4MjQxYg%3D%3D",mime_type:a,width:o,height:o,file_size:o},{url:"http:\u002F\u002Fvod.foxbusiness.com\u002Fmedia\u002Fv1\u002Fpmp4\u002Fstatic\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F5791d5f3-fc7a-4f44-bcf1-5433390876d2\u002Fmain.mp4",mime_type:eJ,width:cB,height:cC,file_size:eK},{url:"https:\u002F\u002Fvod.foxbusiness.com\u002Fmedia\u002Fv1\u002Fpmp4\u002Fstatic\u002Fclear\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002F5791d5f3-fc7a-4f44-bcf1-5433390876d2\u002Fmain.mp4",mime_type:eJ,width:cB,height:cC,file_size:eK}],thumbnail:{poster:{src:av,sources:[{src:av,height:cC,width:cB}]},thumbnail:{src:eL,sources:[{src:eL,height:90,width:160}]}},media_tags:["on_air",ez,"personality","personality|charles_payne",cD,"markets|stocks","markets|wall_street","technology|healthcare",eM,"markets|mergers_acquisitions"],start_air_date:"2024-02-27T19:52:14.000Z",bc_account_id:"854081161001"},tags:[{id:eN,spark_id:eN,external_id:a,parent_external_id:a,path:"fox-business\u002Fshows\u002Fv-what-to-watch",slug:"v-what-to-watch",external_uri:a,parent_external_uri:a,title:eO,label:eO,tag_type:A},{id:eP,spark_id:eP,external_id:a,parent_external_id:a,path:"fox-business\u002Fshows",slug:cA,external_uri:a,parent_external_uri:a,title:eQ,label:eQ,tag_type:A},{id:eR,spark_id:eR,external_id:a,parent_external_id:a,path:"fox-business\u002Fshows\u002Fv-latest-clips-making-money",slug:"v-latest-clips-making-money",external_uri:a,parent_external_uri:a,title:eS,label:eS,tag_type:A},{id:eT,spark_id:eT,external_id:a,parent_external_id:a,path:"fox-business\u002Fshows\u002Fmaking-money-with-charles-payne",slug:eH,external_uri:a,parent_external_uri:a,title:X,label:X,tag_type:a},{id:eU,spark_id:eU,external_id:a,parent_external_id:a,path:eV,slug:cD,external_uri:a,parent_external_uri:a,title:x,label:x,tag_type:A},{id:eW,spark_id:eW,external_id:a,parent_external_id:a,path:"fox-business\u002Fmarkets\u002Fwall-street",slug:"wall-street",external_uri:a,parent_external_uri:a,title:eX,label:eX,tag_type:a},{id:eY,spark_id:eY,external_id:a,parent_external_id:a,path:"fox-business\u002Ftechnology\u002Fhealth-care-tech",slug:"health-care-tech",external_uri:a,parent_external_uri:a,title:eZ,label:eZ,tag_type:a},{id:e_,spark_id:e_,external_id:a,parent_external_id:a,path:"fox-business\u002Ftechnology",slug:eM,external_uri:a,parent_external_uri:a,title:aw,label:aw,tag_type:A},{id:e$,spark_id:e$,external_id:a,parent_external_id:a,path:"fox-business\u002Fmarkets\u002Fmergers-and-acquisitions",slug:"mergers-and-acquisitions",external_uri:a,parent_external_uri:a,title:fa,label:fa,tag_type:a}],category:{page_url:fb,spark_id:fc,description:a,wp__origin:{site:q,environment:p,blog_id:n,source:r,term_id:5,taxonomy_type:"category"},label:x,media_tags:["primary_markets"],published:h,title:x,canonical_url:fb,fn__type:"sections",path:eV,created_date:"2018-06-06T16:28:50-04:00",id:fc,post_status:D,slug:cD},comments:c,expiration_date:a,original_import_date:"2024-03-02T12:17:38Z"},significantArticles:[{title:"Anxiety is biggest concern among employees seeking mental health services, study finds: ‘Major concern’",description:"Last year, nearly a quarter of people who sought mental health treatment through their employers cited anxiety as their main issue, according to a study by ComPsych Corporation.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F04\u002Fanxiety-at-work.jpg",articleUrl:"\u002Ffox-news-health\u002Fanxiety-biggest-concern-employees-seeking-mental-health-services-study-finds-major-concern",category:e,categoryUrl:g,breakingNewsEndDate:a,overlayType:f,tags:[{name:"Stress and Anxiety",url:"\u002Fcategory\u002Ffox-news-stress-and-anxiety"},{name:"Career",url:"\u002Fcategory\u002Fcareer"},{name:K,url:"\u002Fcategory\u002Ffox-news-jobs"},{name:cE,url:cF},{name:i,url:m},{name:e,url:g}],contributors:[{uuidv5:ac,fn__type:j,person_id:ad,name_id:ae,canonical_url:v,page_url:v,first_name:af,last_name:ag,full_name:t,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:t,blog_urls:[],full_bio_url:a,company_name:a,short_bio:ah}],date:"2024-04-12T13:27:20-04:00",stock:b,pill:b},{title:"Disney parks will issue lifetime bans for people who lie about disabilities",description:"Guests at the Disneyland and Disney World amusement parks who make false statements on disability needs to gain access services will be banned for life, according to an announcement from Disney.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2023\u002F08\u002F77a56261-2.jpg",articleUrl:"\u002Flifestyle\u002Fdisney-parks-issue-lifetime-bans-people-lie-disabilities",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:fd,url:"\u002Fcategory\u002Fdisney"},{name:fd,url:"\u002Fcategory\u002Ffox-news-disney"},{name:"Walt Disney World Orlando",url:"\u002Fcategory\u002Ffox-news-walt-disney-world-orlando"},{name:e,url:g},{name:cG,url:cH}],contributors:[{uuidv5:"e895559d-0add-5cb8-921f-459261297b0b",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fn\u002Ftimothy-nerozzi",name_id:"timothy-hj-nerozzi",canonical_url:fe,page_url:fe,first_name:"Timothy",last_name:"Nerozzi",full_name:ff,middle_initial:"H.J.",personality_name:a,prefix:a,role:l,job_title:E,title:ff,blog_urls:["https:\u002F\u002Ftimothynerozzi.com\u002F"],full_bio_url:a,company_name:"Fox Business",short_bio:"\u003Cp\u003ETimothy Nerozzi is a writer for Fox News Digital. You can send tips to Twitter @timothynerozzi and can email him at timothy.nerozzi@fox.com\u003C\u002Fp\u003E"}],date:"2024-04-12T07:19:16-04:00",stock:b,pill:b},{title:"Artificial beauty: Warning of threats to girls’ self-esteem, Dove recommits to never using AI in ads",description:"As experts predict that 90% of online content could be generated by artificial intelligence by 2025, a major beauty brand is taking a stand against the use of AI in advertising.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F04\u002Fbeauty-ideas-AI.jpg",articleUrl:"\u002Ffox-news-lifestyle\u002Fartificial-beauty-warning-threats-girls-self-esteem-dove-recommits-never-using-ai-ads",category:i,categoryUrl:J,breakingNewsEndDate:a,overlayType:f,tags:[{name:fg,url:L},{name:"Style + Beauty",url:"\u002Fcategory\u002Ffox-news-style-and-beauty"},{name:"BEAUTY AND SKIN",url:"\u002Fcategory\u002Ffox-news-beauty-and-skin"},{name:B,url:J},{name:i,url:m},{name:cE,url:cF},{name:e,url:g},{name:y,url:ax}],contributors:[{uuidv5:ac,fn__type:j,person_id:ad,name_id:ae,canonical_url:v,page_url:v,first_name:af,last_name:ag,full_name:t,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:t,blog_urls:[],full_bio_url:a,company_name:a,short_bio:ah}],date:"2024-04-09T09:06:34-04:00",stock:"UL",pill:b},{title:"Bird flu in Texas: Largest US egg producer temporarily shutters facility after H5N1 virus found in chickens",description:"Cal-Maine Foods says it has temporarily closed an egg production facility in Texas after H5N1 bird flu there wiped out nearly two million chickens.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F04\u002FRoosters-Texas.jpg",articleUrl:"\u002Feconomy\u002Fbird-flu-texas-largest-us-egg-producer-temporarily-shutters-facility-h5n1-virus-found-chickens",category:F,categoryUrl:G,breakingNewsEndDate:a,overlayType:f,tags:[{name:fh,url:fi},{name:"INFECTIOUS DISEASE",url:"\u002Fcategory\u002Ffox-news-infectious-disease"},{name:e,url:g},{name:F,url:G}],contributors:[{uuidv5:"21e4f8e9-ab79-5af4-a7e2-ec7ec65af093",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fn\u002Fgreg-norman",name_id:"greg-norman",canonical_url:fj,page_url:fj,first_name:"Greg",last_name:"Norman",full_name:fk,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:fk,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EGreg Norman is a reporter at Fox News Digital. \u003C\u002Fp\u003E"}],date:"2024-04-03T08:54:30-04:00",stock:"CALM",pill:b},{title:"Asleep on the job: Here's how many Americans admit to napping during work hours",description:"A new survey from Sleep Doctor found nearly half of American workers admit to sleeping during work hours on occasion – and one in three do so on a regular basis.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2023\u002F03\u002Fsleeping-worker.jpg",articleUrl:"\u002Flifestyle\u002Fasleep-on-the-job-heres-how-many-americans-admit-napping-during-work-hours",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:i,url:m},{name:K,url:fl},{name:e,url:g},{name:F,url:G}],contributors:[{uuidv5:cI,fn__type:j,person_id:cJ,name_id:cK,canonical_url:M,page_url:M,first_name:cL,last_name:cM,full_name:N,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:N,blog_urls:[],full_bio_url:cN,company_name:a,short_bio:cO}],date:"2024-04-03T07:00:52-04:00",stock:b,pill:b},{title:"Costco launches weight loss program for members",description:"Costco members are now getting access to a weight loss program through Sesame. Through the program, they might be able to get highly coveted weight loss medications.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002Fcostco.jpg",articleUrl:"\u002Flifestyle\u002Fcostco-launches-weight-loss-program-for-members",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:"Costco",url:"\u002Fcategory\u002Fcostco"},{name:y,url:ax},{name:ay,url:cP},{name:e,url:g},{name:W,url:cq}],contributors:[{uuidv5:cQ,fn__type:j,person_id:cR,name_id:cS,canonical_url:O,page_url:O,first_name:cT,last_name:cU,full_name:P,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:P,blog_urls:[],full_bio_url:cV,company_name:cW,short_bio:cX}],date:"2024-04-02T19:08:55-04:00",stock:"COST",pill:b},{title:"US taking the plunge on bidets four years after toilet paper shortage wiped store shelves",description:"A new report in The Washington Post detailed how more Americans are opting to purchase bidets in order to lessen their reliance on toilet paper.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FBidet-expert.png",articleUrl:"\u002Fmedia\u002Fus-plunge-bidets-four-years-toilet-paper-shortage-wiped-store-shelves",category:fm,categoryUrl:fn,breakingNewsEndDate:a,overlayType:f,tags:[{name:fm,url:fn},{name:e,url:g},{name:fo,url:fp}],contributors:[{uuidv5:"8ff7ff36-f306-5f89-baf8-ad0ef286be9c",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fh\u002Fgabriel-hays",name_id:"gabriel-hays",canonical_url:fq,page_url:fq,first_name:"Gabriel",last_name:"Hays",full_name:fr,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:fr,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EGabriel has previously written for both the Media Research Center's MRC Culture and MRCTV departments, covering \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fcategory\u002Fpolitics\u002Fjudiciary\u002Fabortion\" target=\"_blank\"\u003Epro-life\u003C\u002Fa\u003E, religious and other social issues. His beat also covered political bias in Hollywood and the broader \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002Fentertainment\" target=\"_blank\"\u003Eentertainment world\u003C\u002Fa\u003E.\u003C\u002Fp\u003E"}],date:"2024-03-23T06:00:32-04:00",stock:b,pill:b},{title:"Boy, 12, taken to hospital after he was mistakenly served alcohol at Outback Steakhouse",description:"A 12-year-old boy was rushed to a hospital after he was mistakenly served an alcoholic beverage at an Outback Steakhouse in Michigan and had a reaction.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2022\u002F01\u002FiStock-459393407.jpg",articleUrl:"\u002Flifestyle\u002Fboy-12-taken-hospital-mistakenly-served-alcohol-outback-steakhouse",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:cY,url:H},{name:"Kids",url:"\u002Fcategory\u002Ffox-news-kids"},{name:"Restaurants",url:"\u002Fcategory\u002Ffox-news-restaurants"},{name:"DRINKS",url:"\u002Fcategory\u002Ffox-news-drinks"},{name:e,url:g},{name:"Michigan",url:"\u002Fcategory\u002Ffox-news-michigan"}],contributors:[{uuidv5:cI,fn__type:j,person_id:cJ,name_id:cK,canonical_url:M,page_url:M,first_name:cL,last_name:cM,full_name:N,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:N,blog_urls:[],full_bio_url:cN,company_name:a,short_bio:cO}],date:"2024-03-21T18:45:42-04:00",stock:"BLMN",pill:b},{title:"Nvidia announces AI-powered health care 'agents' that outperform nurses — and cost $9 an hour",description:"Nvidia has partnered with artificial intelligence health care company Hippocratic AI to develop an \"agent\" that outperforms nurses on phone calls with patients.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2021\u002F05\u002FNurse-iStock.jpg",articleUrl:"\u002Ftechnology\u002Fnvidia-announces-ai-powered-health-care-agents-outperform-nurses-cost-9-hour",category:aw,categoryUrl:Q,breakingNewsEndDate:a,overlayType:f,tags:[{name:fg,url:L},{name:ay,url:"\u002Fcategory\u002Fhealth-care"},{name:Y,url:"\u002Fcategory\u002Ftech"},{name:e,url:g},{name:K,url:fl}],contributors:[{uuidv5:cI,fn__type:j,person_id:cJ,name_id:cK,canonical_url:M,page_url:M,first_name:cL,last_name:cM,full_name:N,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:N,blog_urls:[],full_bio_url:cN,company_name:a,short_bio:cO}],date:"2024-03-21T18:01:20-04:00",stock:"NVDA",pill:b},{title:"Real-life cat burglary suspect does yoga before raiding bakery store: video",description:"A real-life cat burglar was captured on video stretching and doing yoga outside a bakery earlier this month – before going on to burglarize the place minutes later.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FFlexible-bandit.jpg",articleUrl:"\u002Fsmall-business\u002Freal-life-cat-burglary-suspect-yoga-raiding-bakery-store-video",category:R,categoryUrl:fs,breakingNewsEndDate:a,overlayType:f,tags:[{name:"Crime",url:"\u002Fcategory\u002Fcrime"},{name:"Australia",url:"\u002Fcategory\u002Ffox-news-australia"},{name:R,url:fs},{name:e,url:g},{name:"Fitness",url:"\u002Fcategory\u002Ffitness"},{name:"Robbery - Theft",url:"\u002Fcategory\u002Ffox-news-robbery-theft"}],contributors:[{uuidv5:"a8669faa-8c75-5796-bd1a-98506bbd01f8",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fd\u002Fmichael-dorgan",name_id:"michael-dorgan",canonical_url:ft,page_url:ft,first_name:"Michael",last_name:"Dorgan",full_name:fu,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:cZ,title:fu,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EMichael Dorgan is a Fox News Digital breaking news writer. \u003C\u002Fp\u003E"}],date:"2024-03-20T11:40:55-04:00",stock:b,pill:b},{title:"Trader Joe's cashews recalled in 16 states due to salmonella risk",description:"Customers who purchased cashews from Trader Joe's stores in 16 states are suggested to look over the packages to see if they are part of a recall announced Sunday.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FTJ-Cashews.jpg",articleUrl:"\u002Fretail\u002Ftrader-joes-cashews-recalled-16-states-due-salmonella-risk",category:y,categoryUrl:ax,breakingNewsEndDate:a,overlayType:f,tags:[{name:fv,url:"\u002Fcategory\u002Fproduct-recalls"},{name:fv,url:"\u002Fcategory\u002Ffox-news-product-recalls"},{name:y,url:ax},{name:e,url:g},{name:"DIGESTIVE HEALTH",url:"\u002Fcategory\u002Ffox-news-digestive-health"}],contributors:[{uuidv5:"30f68e9e-e7c8-52c5-8fe7-4092a4d57820",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fa\u002Fpilar-arias",name_id:"pilar-arias",canonical_url:fw,page_url:fw,first_name:"Pilar",last_name:"Arias",full_name:fx,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:fx,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EPilar Arias is a multimedia journalist with more than 10 years of experience in broadcast, digital and print production. She enjoys covering a wide variety of topics. Follow her on Twitter: \u003Ca href=\"https:\u002F\u002Ftwitter.com\u002FPilarFOXNews\" target=\"_blank\"\u003E@PilarFOXNews.\u003C\u002Fa\u003E\u003C\u002Fp\u003E"}],date:"2024-03-19T10:43:39-04:00",stock:b,pill:b},{title:"EPA finalizes ban on last form of asbestos used in US",description:"The U.S. Environmental Protection Agency has finalized a rule to ban the use and importation of asbestos, marking the first chemical banned under a 2016 chemical safety law.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FAsbestos-Sign.jpg",articleUrl:"\u002Ffox-news-us\u002Fepa-finalizes-ban-last-form-asbestos-used-us",category:cG,categoryUrl:cH,breakingNewsEndDate:a,overlayType:f,tags:[{name:e,url:g},{name:"Reuters",url:"\u002Fcategory\u002Freuters"},{name:"CANCER",url:"\u002Fcategory\u002Ffox-news-cancer"},{name:"Law",url:"\u002Fcategory\u002Ffox-news-law"},{name:"ENVIRONMENT",url:"\u002Fcategory\u002Ffox-news-environment"}],contributors:b,date:"2024-03-18T13:22:46-04:00",stock:b,pill:b},{title:"President Biden to release budget proposal with tax and spending policies",description:"President Joe Biden is set to unveil his budget proposal for fiscal year 2025 that is expected to include tax and spending policies that will form part of his re-election platform.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FPresident-Biden-SOTU-Budget.jpg",articleUrl:"\u002Fpolitics\u002Fpresident-biden-release-budget-proposal-with-tax-spending-policies",category:fy,categoryUrl:fz,breakingNewsEndDate:a,overlayType:f,tags:[{name:"Joe Biden",url:"\u002Fcategory\u002Fjoe-biden"},{name:"Housing",url:"\u002Fcategory\u002Ffox-news-housing"},{name:"Taxes",url:"\u002Fcategory\u002Ftaxes"},{name:e,url:g},{name:"Medicare",url:"\u002Fcategory\u002Fmedicare"},{name:"White House",url:"\u002Fcategory\u002Fwhite-house"},{name:fy,url:fz}],contributors:[{uuidv5:"e667781b-54de-542f-b9d4-0a741e08e3e3",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fr\u002Feric-revell",name_id:"eric-revell",canonical_url:fA,page_url:fA,first_name:"Eric",last_name:"Revell",full_name:fB,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:cZ,title:fB,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EEric Revell is a writer for \u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002F\" target=\"_blank\"\u003EFOX Business\u003C\u002Fa\u003E and \u003Ca href=\"https:\u002F\u002Fwww.foxnews.com\u002F\" target=\"_blank\"\u003EFox News\u003C\u002Fa\u003E Digital. He has covered \u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Fpolitics\" target=\"_blank\"\u003Epolitics\u003C\u002Fa\u003E and the \u003Ca href=\"https:\u002F\u002Fwww.foxbusiness.com\u002Fcategory\u002Fus-economy\" target=\"_blank\"\u003Eeconomy\u003C\u002Fa\u003E and holds degrees from the University of Oregon and Oregon State University.\u003C\u002Fp\u003E"}],date:"2024-03-11T07:00:42-04:00",stock:b,pill:b},{title:k,description:S,imageUrl:u,articleUrl:cx,category:e,categoryUrl:g,breakingNewsEndDate:a,overlayType:f,tags:[{name:e,url:g},{name:V,url:cp},{name:W,url:cq},{name:an,url:ej},{name:ap,url:ek},{name:i,url:m},{name:B,url:J}],contributors:[{uuidv5:ac,fn__type:j,person_id:ad,name_id:ae,canonical_url:v,page_url:v,first_name:af,last_name:ag,full_name:t,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:a,title:t,blog_urls:[],full_bio_url:a,company_name:a,short_bio:ah}],date:C,stock:er,pill:b},{title:"Mars Wrigley pitches new idea to get Americans back into chewing gum",description:"Mars Inc., which owns Wrigley, is hoping to get Americans and other consumers back into chewing gum and has a new idea on how to do it.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FGettyImages-605585162.jpg",articleUrl:"\u002Flifestyle\u002Fmars-wrigley-pitches-new-idea-get-americans-chewing-gum",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:i,url:m},{name:cE,url:cF},{name:e,url:g},{name:fo,url:fp}],contributors:[{uuidv5:"e727c6ce-ecae-56a1-8b66-5dcde5c4c230",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fr\u002Flawrence-richard",name_id:"lawrence-richard",canonical_url:fC,page_url:fC,first_name:"Lawrence",last_name:"Richard",full_name:fD,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:fE,title:fD,blog_urls:[],full_bio_url:"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Flawrence-richard-419928198\u002F",company_name:a,short_bio:a}],date:"2024-03-07T08:40:34-05:00",stock:b,pill:b},{title:"Companies can claim yogurt reduces diabetes risk, FDA says",description:"The FDA said it doesn't object to qualified claims that yogurt may reduce the risk of Type 2 diabetes. But companies have to be careful not to mislead consumers with their wording.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002Fyogurt.jpg",articleUrl:"\u002Flifestyle\u002Fcompanies-can-claim-yogurt-reduces-diabetes-risk-fda-says",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:ay,url:cP},{name:cY,url:H},{name:"DIABETES",url:"\u002Fcategory\u002Ffox-news-diabetes"},{name:fh,url:fi},{name:e,url:g},{name:fF,url:fG}],contributors:[{uuidv5:cQ,fn__type:j,person_id:cR,name_id:cS,canonical_url:O,page_url:O,first_name:cT,last_name:cU,full_name:P,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:P,blog_urls:[],full_bio_url:cV,company_name:cW,short_bio:cX}],date:"2024-03-06T17:18:00-05:00",stock:b,pill:b},{title:"Cancer-causing chemical linked to popular acne products, lab says",description:"An independent lab is warning the FDA of recent findings that certain benzoyl peroxide acne treatment products can form high levels of a chemical linked to cancer.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002FValisure.jpg",articleUrl:"\u002Flifestyle\u002Fcancer-chemical-linked-to-popular-acne-products-lab-reports",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:ay,url:cP},{name:fF,url:fG},{name:e,url:g}],contributors:[{uuidv5:cQ,fn__type:j,person_id:cR,name_id:cS,canonical_url:O,page_url:O,first_name:cT,last_name:cU,full_name:P,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:E,title:P,blog_urls:[],full_bio_url:cV,company_name:cW,short_bio:cX}],date:"2024-03-06T15:01:39-05:00",stock:b,pill:b},{title:"With Flovent inhaler off the market, some parents face challenges in getting generics for kids with asthma",description:"After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued in January, some parents are reporting challenges in obtaining the generic versions of the medication.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F01\u002Fflovent-hfa-box.jpg",articleUrl:"\u002Ffox-news-health\u002Fflovent-inhaler-market-parents-face-challenges-getting-generics-kids-asthma",category:e,categoryUrl:g,breakingNewsEndDate:a,overlayType:f,tags:[{name:e,url:g},{name:"Children's Health",url:"\u002Fcategory\u002Ffox-news-childrens-health"},{name:V,url:cp},{name:"Asthma",url:"\u002Fcategory\u002Ffox-news-asthma"},{name:i,url:m},{name:B,url:J},{name:"RESPIRATORY HEALTH",url:"\u002Fcategory\u002Ffox-news-respiratory-health"}],contributors:[{uuidv5:"ca69cead-ebee-5d0f-a82b-e7fb599ca3b5",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fs\u002Fshiv-sudhakar",name_id:"shiv-sudhakar",canonical_url:fH,page_url:fH,first_name:"Shiv",last_name:"Sudhakar",full_name:fI,middle_initial:a,personality_name:a,prefix:a,role:"Contributor",job_title:a,title:fI,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EShiv Sudhakar is a contributing lifestyle reporter. \u003C\u002Fp\u003E"}],date:"2024-03-02T19:49:37-05:00",stock:b,pill:b},{title:"Chocolate bars recalled over milk allergy concerns",description:"A Pennsylvania-based company recalled a bar of chocolate over milk allergy reaction concerns, the Food and Drug Administration announced Wednesday.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F03\u002Ffda-chocolate-recall.jpg",articleUrl:"\u002Flifestyle\u002Fchocolate-bars-recalled-milk-allergy-concerns",category:i,categoryUrl:m,breakingNewsEndDate:a,overlayType:f,tags:[{name:B,url:J},{name:e,url:g},{name:cY,url:H}],contributors:[{uuidv5:"616785b6-4225-5e39-9603-44cc4b121c33",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fc\u002Fhaley-chi-sing",name_id:"haley-chi-sing",canonical_url:fJ,page_url:fJ,first_name:"Haley",last_name:"Chi-Sing",full_name:fK,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:fE,title:fK,blog_urls:[],full_bio_url:a,company_name:a,short_bio:"\u003Cp\u003EHaley Chi-Sing is a Fox News Digital production assistant. You can reach her at @haleychising on Twitter.\u003C\u002Fp\u003E"}],date:"2024-03-02T10:18:27-05:00",stock:b,pill:b},{title:"Person injured after cellphone explodes at DC high school",description:"A person was hospitalized Thursday morning after a cellphone exploded at Roosevelt High School in D.C., according to the city’s fire department.",imageUrl:"https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F02\u002FGHhMs91WoAAKJ1I.jpg",articleUrl:"\u002Ftechnology\u002Fperson-injured-cellphone-explodes-dc-high-school",category:aw,categoryUrl:Q,breakingNewsEndDate:a,overlayType:f,tags:[{name:"Washington DC",url:"\u002Fcategory\u002Ffox-news-washington-dc"},{name:"TECH",url:"\u002Fcategory\u002Ffox-news-tech"},{name:e,url:g},{name:cG,url:cH}],contributors:[{uuidv5:"6b184bd6-f8a2-55f2-9e17-396aad676723",fn__type:j,person_id:"content\u002Ffb\u002Fperson\u002Fp\u002Fstepheny-price",name_id:"stepheny-price",canonical_url:fL,page_url:fL,first_name:"Stepheny",last_name:"Price",full_name:fM,middle_initial:a,personality_name:a,prefix:a,role:l,job_title:cZ,title:fM,blog_urls:[],full_bio_url:a,company_name:a,short_bio:a}],date:"2024-02-29T20:37:33-05:00",stock:b,pill:b}]},{showBreakingNews:c,headerMenuData:{sections:[{subsections:[{name:az,tracking:"nav_personalfinance_mortgages",url:aA},{name:aB,tracking:"nav_personalfinance_studentloans",url:aC},{name:aD,tracking:"nav_personalfinance_creditcards",url:aE},{name:aF,tracking:"nav_personalfinance_personalloans",url:aG},{name:aH,tracking:"nav_personalfinance_savings",url:aI},{name:aJ,tracking:"nav_personalfinance_insurance",url:aK},{name:aL,tracking:"nav_personalfinance_401k",url:aM},{name:"Modern Retirement",tracking:"nav_personalfinance_retirement",url:aN},{name:aO,tracking:"nav_personalfinance_taxplanning",url:aP}],name:aQ,tracking:"nav_personalfinance",url:aR},{subsections:[{name:aS,tracking:"nav_economy_governmentspending",url:aT},{name:"Money &amp; Policy",tracking:"nav_economy_money&amp;policy",url:aU},{name:R,tracking:"nav_economy_smallbusiness",url:aV}],name:F,tracking:"nav_economy",url:G},{subsections:[{name:aW,tracking:"nav_markets_stocks",url:"\u002Fcategory\u002Fstocks"},{name:aX,tracking:"nav_markets_usmarkets",url:aY},{name:aZ,tracking:"nav_markets_cryptocurrency",url:a_},{name:"Futures &amp; Commodities",tracking:"nav_markets_futures&amp;commodities",url:a$},{name:ba,tracking:"nav_markets_bonds",url:bb},{name:bc,tracking:"nav_markets_etfs",url:bd},{name:be,tracking:"nav_markets_businessleaders",url:bf},{name:bg,tracking:"nav_markets_industries",url:bh},{name:y,tracking:"nav_markets_retail",url:bi},{name:"Pre Markets",tracking:"nav_markets_premarkets",url:bj},{name:bk,tracking:"nav_markets_mutualfunds",url:bl}],name:x,tracking:"nav_markets",url:bm},{name:bn,tracking:"nav_watchlist",url:bo},{subsections:[{name:bp,tracking:"nav_lifestyle_entertainment",url:bq},{name:"Rich &amp; Famous",tracking:"nav_lifestyle_rich&amp;famous",url:br},{name:bs,tracking:"nav_lifestyle_travel",url:bt},{name:bu,tracking:"nav_lifestyle_cars",url:bv},{name:bw,tracking:"nav_lifestyle_airplanes",url:bx},{name:"Food &amp; Drinks",tracking:"nav_lifestyle_food&amp;drinks",url:H},{name:by,tracking:"nav_lifestyle_Arts",url:bz}],name:i,tracking:"nav_lifestyle",url:bA},{subsections:[{name:"Personal Real Estate",tracking:"nav_real_estate_personal",url:bB},{name:"Commercial Real Estate",tracking:"nav_real_estate_commercial",url:bC},{name:bD,tracking:"nav_real_estate_luxuryproperties",url:bE}],name:bF,tracking:"nav_real_estate",url:bG},{subsections:[{name:bH,tracking:"nav_tech_digital",url:bI},{name:bJ,tracking:"nav_tech_socialmedia",url:bK},{name:bL,tracking:"nav_tech_gadgets",url:bM},{name:bN,tracking:"nav_tech_businesstech",url:bO},{name:bP,tracking:"nav_tech_healthcaretech",url:bQ},{name:bR,tracking:"nav_tech_futuretech",url:bS},{name:bT,tracking:"nav_tech_ai",url:L},{name:bU,tracking:"nav_tech_space",url:"\u002Fcategory\u002Fspace"}],name:Y,tracking:"nav_tech",url:Q},{subsections:[],name:bV,tracking:"nav_video",url:bW},{name:"Podcasts",tracking:"nav_podcast",url:"\u002F\u002Fradio.foxnews.com\u002Fpodcast"}]},moreMenuData:{sections:[{subsections:[{name:az,id:"d6b236f9-77ba-4558-9693-84955e8ce656",tracking:a,url:aA},{name:aB,id:"48b9c65c-a191-4629-bea9-f911fb4fefd1",tracking:a,url:aC},{name:aD,id:"b85c5727-c3c2-4372-b94c-ee9e9f0aaabb",tracking:a,url:aE},{name:aF,id:"1ea73995-8f49-46e1-b93e-e785eb897ef0",tracking:a,url:aG},{name:aH,id:"c8fb08da-de90-4aa4-8948-6ff5b28cbadb",tracking:a,url:aI},{name:aJ,id:"19a71e49-3347-4719-862c-fd27e2f75df8",tracking:a,url:aK},{name:aL,id:"8d2fa7a5-8519-47d9-a61a-53e0c137c43f",tracking:a,url:aM},{name:c_,id:"45a1b332-d61c-43e5-8b46-77111d7774cf",tracking:a,url:aN},{name:aO,id:"d26f51ac-b0ca-4521-8369-4d7ba2a83f5b",tracking:a,url:aP}],name:aQ,id:"bb1021ef-995a-46b7-98b8-2c37bf08a585",tracking:a,url:aR},{subsections:[{name:aS,id:"e32e1a41-5a92-41c9-bbe2-bf309ead91b1",tracking:a,url:aT},{name:c$,id:"2f6ee3d6-6fe3-4a5d-9b62-72b39aacca72",tracking:a,url:aU},{name:R,id:"c339b81c-a24f-4ccd-b0a0-e86d69710cce",tracking:a,url:aV},{name:da,id:"9ca4d406-285b-4cf5-ac14-cd77f1dcb408",tracking:a,url:db}],name:F,id:"37020436-c657-4765-80b7-25b9bdd71013",tracking:a,url:G},{subsections:[{name:aW,id:"1d35dd7e-474a-45f8-a7fa-2ecc0fb0ff68",tracking:a,url:dc},{name:aX,id:"8cccf71d-82df-45bb-8c2b-42088d73ebe6",tracking:a,url:aY},{name:aZ,id:"0d73b818-5b66-49f4-89b5-4e301b3898fd",tracking:a,url:a_},{name:dd,id:"2fc0c5de-1ab0-41a8-a4f0-e80e326c74dd",tracking:a,url:a$},{name:ba,id:"64da6fae-9702-4087-b392-20d6a209d8a4",tracking:a,url:bb},{name:bc,id:"c7b02e1e-bf98-44d4-b0ad-99b18525de0f",tracking:a,url:bd},{name:be,id:"47bffe6a-5b99-4297-b60a-565257edac9b",tracking:a,url:bf},{name:bg,id:"47e7b086-2d29-42de-a0c6-3c8362827dfc",tracking:a,url:bh},{name:y,id:"58e4514e-1362-4686-93d5-176c8b7f979b",tracking:a,url:bi},{name:de,id:"8c0e727a-e603-458e-acc6-f7707d622b38",tracking:a,url:bj},{name:bk,id:"68457dd6-4d56-4c3c-a15c-e392700e86e1",tracking:a,url:bl}],name:x,id:"9c61638b-f056-4ad4-8142-28ac5b5bea9e",tracking:a,url:bm},{name:bn,id:"3ebdff85-94cf-4c93-b073-8a5c5dd96554",tracking:a,url:bo},{subsections:[{name:bp,id:"c563717a-575c-4b01-81e5-15bac6c71d13",tracking:a,url:bq},{name:df,id:"0a13263e-dfec-429e-b95d-35fe41e8b18c",tracking:a,url:br},{name:bs,id:"77825db2-9753-4d98-9eb5-5bd19a11a31a",tracking:a,url:bt},{name:bu,id:"e4d563d8-3c06-4e03-9fa1-c154b3dd4fbd",tracking:a,url:bv},{name:bw,id:"98c82746-6dcb-42ec-b84d-2df7d2a44fab",tracking:a,url:bx},{name:dg,id:"90e5b2bb-2b5c-4657-bf5b-cdae5bdb2c53",tracking:a,url:H},{name:by,id:"b245e89c-3545-4d0d-b7f9-f19393470eb0",tracking:a,url:bz}],name:i,id:"f9ab9f47-5da8-4cc5-a8ba-35dcd7fa630c",tracking:a,url:bA},{subsections:[{name:dh,id:"36d64596-5d6a-4163-9a2f-ddeb65b8714e",tracking:a,url:bB},{name:di,id:"cca97bd9-5c26-414c-b5cf-06ec1f8aecba",tracking:a,url:bC},{name:bD,id:"f11f76cd-1b17-4e14-a7e3-b664e61f5b67",tracking:a,url:bE}],name:bF,id:"d2c8049f-275f-435e-8476-b370bc05cee4",tracking:a,url:bG},{subsections:[{name:bH,id:"a0672858-ed20-404b-9844-c76bf3214d57",tracking:a,url:bI},{name:bJ,id:"588e2fac-a5c2-4d8d-9684-d37d13f9ec48",tracking:a,url:bK},{name:bL,id:"efd6b7d8-3393-4581-b93e-4dede9e47de5",tracking:a,url:bM},{name:bN,id:"172ecef6-b462-4a38-94f6-d48d227ef691",tracking:a,url:bO},{name:bP,id:"db4b7128-121d-421e-98c2-6f420fb6201a",tracking:a,url:bQ},{name:bR,id:"48f725a6-6cdb-4a26-9b1b-a45ba7b50d37",tracking:a,url:bS},{name:bT,id:"53f0c93b-b032-4551-a48b-383008134d33",tracking:a,url:L},{name:bU,id:"40b09769-59ef-4fa6-8ae3-e3065e49edbe",tracking:a,url:dj}],name:Y,id:"bd2da521-23e7-4a35-b29b-19871ef13d43",tracking:a,url:Q},{subsections:[{name:dk,id:"e23a60a9-89dd-4e0c-936e-3769b2cffcbd",tracking:a,url:dl},{name:dm,id:"435d2f76-7f5f-4109-9c35-39ab88e164ea",tracking:a,url:dn},{name:do0,id:"7ef8ea61-18f1-45a8-b46d-3e5eeefd412e",tracking:a,url:dp},{name:dq,id:"5e408a9f-a12b-420c-b619-40488cf05224",tracking:a,url:dr},{name:ds,id:"0d48dea0-20eb-4224-986a-a9700a6d1590",tracking:a,url:dt},{name:du,id:"29a63ae0-1deb-4388-b644-dc91a63ea080",tracking:a,url:dv},{name:dw,id:"d27d695c-a30b-43eb-99b3-06d0fec00135",tracking:a,url:dx},{name:dy,id:"512b83c2-41fa-4d43-bbbb-673befe1836f",tracking:a,url:dz}],name:dA,id:"3b7f29cc-19a8-4a9c-bda6-db734bbbe3b9",tracking:a,url:dB},{name:dC,id:"1ab49983-5a03-45d4-b7be-a67d66761bdf",tracking:a,url:dD},{name:bV,id:"dd0e2a82-e603-4ede-92b0-5485fb9e7d6d",tracking:a,url:bW},{subsections:[{name:dE,id:"17f9bf56-93b0-497a-a6d6-5d7c1ac6175b",tracking:a,url:dF},{name:K,id:"b71a61ef-5f7f-4f12-b2fe-ab7948d36efb",tracking:a,url:dG},{name:dH,id:"37ae4169-c90f-49a6-b7f2-40d412849724",tracking:a,url:Z},{name:dI,id:"76518604-6e7d-438b-943a-f6977de4d39f",tracking:a,url:_},{name:dJ,id:"474d4ed5-59a2-4091-8240-675c089157c5",tracking:a,url:dK},{name:dL,id:"b023aa1e-f15f-47c8-8dc4-654e81fe0250",tracking:a,url:dM},{name:dN,id:"5d970b40-3630-4dad-9bd2-2c0c7a61d26a",tracking:a,url:dO},{name:$,id:"bc115b04-e21c-4dbd-85d7-198f34740ec3",tracking:a,url:dP},{name:dQ,id:"55079b0b-4d9e-453f-9172-d630ad547b87",tracking:a,url:dR},{name:dS,id:"dbd47528-a8fd-4d2f-b40c-4293dc15d675",tracking:a,url:dT},{name:dU,id:"7b8faf16-0dba-4171-a9f5-4456232653ab",tracking:a,url:dV},{name:dW,id:"aaeb5d16-9295-4100-a649-86873960630e",tracking:a,url:dX},{name:dY,id:"ab0ba2cf-7149-48df-a961-012ce2ce6f71",tracking:a,url:dZ}],name:d_,id:"ce05f454-2a40-4be8-8881-f5676f85b7fd",tracking:a,url:d$}]}},{legalLinksMenuData:[{name:fN,tracking:fO,url:Z},{name:fP,tracking:fQ,url:_},{name:fR,tracking:fS,url:fT},{name:fU,tracking:fV,url:fW},{name:$,tracking:fX,url:fY}]},{currentUrl:a,footerMenuData:{sections:[{subsections:[{name:az,tracking:a,url:aA},{name:aB,tracking:a,url:aC},{name:aD,tracking:a,url:aE},{name:aF,tracking:a,url:aG},{name:aH,tracking:a,url:aI},{name:aJ,tracking:a,url:aK},{name:aL,tracking:a,url:aM},{name:c_,tracking:a,url:aN},{name:aO,tracking:a,url:aP},{name:"FOX Money",tracking:a,url:"\u002Ffox-money"}],name:aQ,tracking:"fbnnav1",url:aR},{subsections:[{name:aS,tracking:a,url:aT},{name:c$,tracking:a,url:aU},{name:R,tracking:a,url:aV},{name:da,tracking:a,url:db}],name:F,tracking:a,url:G},{subsections:[{name:aW,tracking:a,url:dc},{name:aX,tracking:a,url:aY},{name:aZ,tracking:a,url:a_},{name:dd,tracking:a,url:a$},{name:ba,tracking:a,url:bb},{name:bc,tracking:a,url:bd},{name:be,tracking:a,url:bf},{name:bg,tracking:a,url:bh},{name:y,tracking:a,url:bi},{name:de,tracking:a,url:bj},{name:bk,tracking:a,url:bl}],name:x,tracking:a,url:bm},{name:bn,tracking:a,url:bo},{subsections:[{name:bp,tracking:a,url:bq},{name:df,tracking:a,url:br},{name:bs,tracking:a,url:bt},{name:bu,tracking:a,url:bv},{name:bw,tracking:a,url:bx},{name:dg,tracking:a,url:H},{name:by,tracking:a,url:bz}],name:i,tracking:a,url:bA},{subsections:[{name:dh,tracking:a,url:bB},{name:di,tracking:a,url:bC},{name:bD,tracking:a,url:bE}],name:bF,tracking:a,url:bG},{subsections:[{name:bH,tracking:a,url:bI},{name:bJ,tracking:a,url:bK},{name:bL,tracking:a,url:bM},{name:bN,tracking:a,url:bO},{name:bP,tracking:a,url:bQ},{name:bR,tracking:a,url:bS},{name:bT,tracking:a,url:L},{name:bU,tracking:a,url:dj}],name:Y,tracking:a,url:Q},{subsections:[{name:dk,tracking:a,url:dl},{name:dm,tracking:a,url:dn},{name:do0,tracking:a,url:dp},{name:dq,tracking:a,url:dr},{name:ds,tracking:a,url:dt},{name:du,tracking:a,url:dv},{name:dw,tracking:a,url:dx},{name:dy,tracking:a,url:dz}],name:dA,tracking:a,url:dB},{name:dC,tracking:a,url:dD},{name:bV,tracking:a,url:bW},{subsections:[{name:dE,tracking:a,url:dF},{name:K,tracking:a,url:dG},{name:dH,tracking:a,url:Z},{name:dI,tracking:a,url:_},{name:dJ,tracking:a,url:dK},{name:dL,tracking:a,url:dM},{name:dN,tracking:a,url:dO},{name:$,tracking:a,url:dP},{name:dQ,tracking:a,url:dR},{name:dS,tracking:a,url:dT},{name:dU,tracking:a,url:dV},{name:dW,tracking:a,url:dX},{name:dY,tracking:a,url:dZ}],name:d_,tracking:a,url:d$}]}},{legalLinksMenuData:[{name:fN,tracking:fO,url:Z},{name:fP,tracking:fQ,url:_},{name:fR,tracking:fS,url:fT},{name:fU,tracking:fV,url:fW},{name:$,tracking:fX,url:fY}]}],error:s,state:{Layouts:{raw:{navLayout:{elementId:s,isDefault:h,publication_date:"2023-05-15T16:16:50-04:00","main-content":[fZ],id:"eae631c6-8a8c-5dd1-99f3-21c5efafbd8b"},breakingNews:{elementId:s,isDefault:h,publication_date:"2023-09-28T01:07:42-04:00","main-content":[f_],id:"deb43868-95ed-56c7-8ab1-e4cd55147651"}},breakingNews:{mainContent:[f_],rightRail:[],preContent:[]},navLayout:{mainContent:[fZ],rightRail:[],preContent:[]}},Markets:{relatedArticles:[],rightRailStocksRaw:[],stockDetailedInfoRaw:{},stockCompanyInfo:{}},Search:{query:{},numPages:o,currentPage:n,numFound:s,currentResults:[],searchTerm:a,sortingMethod:"Relevance",fetching:h},Tv:{weekSchedule:[],featuredSchedule:[]},Video:{auth:{},mvpd:{},theme:a,isCommentsEnabled:h,isCommentsVisible:c,schedule:{timestamp:a,data:[]}}},serverRendered:h,routePath:cx,config:{}}}("",void 0,false,"paragraph","Health","article","\u002Fcategory\u002Ffox-news-health",true,"Lifestyle","persons","Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug","Author","\u002Fcategory\u002Flifestyle",1,0,"production","cms.foxbusiness.com","tiger-cms",null,"Melissa Rudy","https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2023\u002F08\u002FWegovy.jpg","foxbusiness.com\u002Fperson\u002Fr\u002Fmelissa-rudy","fox-news-health","Markets","Retail","image","keyword","LIFESTYLE","2024-03-09T08:05:50-05:00","publish","Reporter","Economy","\u002Feconomy","\u002Fcategory\u002Ffood-drinks","attachment","\u002Fcategory\u002Ffox-news-lifestyle","Jobs","\u002Fcategory\u002Fartificial-intelligence","foxbusiness.com\u002Fperson\u002Fd\u002Fbreck-dumas","Breck Dumas","foxbusiness.com\u002Fperson\u002Fg\u002Fdaniella-genovese","Daniella Genovese","\u002Ftechnology","Small Business","Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.","Wegovy","Getty Images","Medications","Weight Loss","Making Money with Charles Payne","Tech","\u002Fterms-of-use","\u002Fprivacy-policy","Closed Captioning Policy","Carsten Snejbjerg\u002FBloomberg via Getty Images","source","b1657b96-0493-5ca6-bfb5-60a9fcbaf8e3","content\u002Ffb\u002Fperson\u002Fr\u002Fmelissa-rudy","melissa-rudy","Melissa","Rudy","\u003Cp\u003EMelissa Rudy, health editor, is a member of the Lifestyle team at Fox News Digital. \u003C\u002Fp\u003E","36de9754-06a8-5f47-a5c4-0f29c1e5ab46","fox-news\u002Ffox-news-newsedge\u002Ffox-news-health","d07db6b3-ecbd-5548-979d-b6d019081780","0776dc28-5348-5fe4-81b0-62d820124d62","ba01865a-e5bf-5a2f-adf6-206e28066ec8","Obesity","7d6427bd-51ed-5a3b-8ecd-8f52dd1417a0","HEART HEALTH","302aab5e-fc74-5ba2-9b69-454970ee3ead","lifestyle","e8f0a499-ce0b-53a5-adc4-e3e4cc99a181","bb17cac0-daf4-5f6c-aedf-6336408c9966","2024-03-09T09:00:40-05:00","https:\u002F\u002Fcf-images.us-east-1.prod.boltdns.net\u002Fv1\u002Fstatic\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002Fe280edcf-0404-42c0-bdc3-9043c3f1786f\u002F1280x720\u002Fmatch\u002Fimage.jpg","Technology","\u002Fretail","Health Care","Mortgages","\u002Fcategory\u002Fmortgage","Student Loans","\u002Fcategory\u002Fstudent-loans","Credit Cards","\u002Fcategory\u002Fcredit-cards","Personal Loans","\u002Fcategory\u002Fpersonal-loans","Savings","\u002Fcategory\u002Fsavings","Insurance","\u002Fcategory\u002Finsurance","401k","\u002Fcategory\u002F401k","\u002Fcategory\u002Fmodern-retirement","Tax Planning","\u002Fcategory\u002Ftax-planning","Personal Finance","\u002Fpersonal-finance","Government Spending","\u002Fcategory\u002Fgovernment-spending","\u002Fcategory\u002Fmoney-and-policy","\u002Fcategory\u002Fsmall-business","Stocks","US Markets","\u002Fcategory\u002Fus-markets","Cryptocurrency","\u002Fcategory\u002Fcryptocurrency","\u002Fcategory\u002Ffutures-commodities","Bonds","\u002Fcategory\u002Fbonds","ETFs","\u002Fcategory\u002Fetfs","Business Leaders","\u002Fcategory\u002Fbusiness-leaders","Industries","\u002Fcategory\u002Findustries","\u002Fcategory\u002Fretail","\u002Fcategory\u002Fpre-markets","Mutual Funds","\u002Fcategory\u002Fmutual-funds","\u002Fmarkets","Watchlist","\u002Fwatchlist","Entertainment","\u002Fcategory\u002Fentertainment","\u002Fcategory\u002Frich-famous","Travel","\u002Fcategory\u002Ftravel","Cars","\u002Fcategory\u002Fcars","Airplanes","\u002Fcategory\u002Fairplanes","Arts","\u002Fcategory\u002Farts","\u002Flifestyle","\u002Fcategory\u002Fpersonal-real-estate","\u002Fcategory\u002Fcommercial-real-estate","Luxury Properties","\u002Fcategory\u002Fluxury-properties","Real Estate","\u002Freal-estate","Digital","\u002Fcategory\u002Fdigital","Social Media","\u002Fcategory\u002Fsocial-media","Gadgets","\u002Fcategory\u002Fgadgets","Business Tech","\u002Fcategory\u002Fbusiness-tech","Healthcare Tech","\u002Fcategory\u002Fhealth-care-tech","Future Tech","\u002Fcategory\u002Ffuture-tech","AI","Space","Video","\u002Fvideo","300x250","Packets of Wegovy move along a conveyor at the Novo Nordisk A\u002FS production facilities in Hillerod, Denmark, on Monday, June 12, 2023. Novo's blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, buoying shares of the Danish drugmaker and the US maker of a potential rival treatment, Eli Lilly &amp; Co. Photographer: Carsten Snejbjerg\u002FBloomberg via Getty Images",2333950,"7fb92dbd-e9b4-5802-b5b1-00d4b8f9a8c6","https:\u002F\u002Fwww.gettyimages.com\u002F","foxbusiness.com\u002Fsource\u002Fgetty-images",2014458,"957e118a-c50d-51de-b6d9-184c7e5833ed","0975dbe9-ee34-5bd7-9e71-60d0a66a19f6","fox-news\u002Ffox-news-health","wegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug","FOXBusiness","https:\u002F\u002Fwww.foxbusiness.com","The injectable semaglutide from Novo Nordisk was shown to reduce risk of cardiovascular death, heart attack and stroke","fox-news\u002Ffox-news-health\u002Ffox-news-healthy-living\u002Ffox-news-medications","fox-news\u002Ffox-news-health\u002Ffox-news-nutrition-and-fitness\u002Ffox-news-weight-loss","fox-news\u002Ffox-news-health\u002Ffox-news-nutrition-and-fitness\u002Ffox-news-obesity","fox-news\u002Ffox-news-health\u002Ffox-news-heart-health","fox-business\u002Flifestyle","fox-news\u002Ffox-news-lifestyle","\u002Fcategory\u002Ffox-news-medications","\u002Fcategory\u002Ffox-news-weight-loss","Original","foxbusiness.com\u002Ffox-news-health\u002Fwegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug","Barbara Ryan Advisors founder Barbara Ryan discusses the future of the biotech sector on 'Making Money.'","full-width-image","center","2024-03-09T14:00:42.137Z","\u002Ffox-news-health\u002Fwegovy-weight-loss-medication-fda-approval-heart-disease-prevention-drug","Charles Payne","f814c717-7626-5ba6-81f6-9de58c3663f3","shows",1280,720,"markets","MENTAL HEALTH","\u002Fcategory\u002Ffox-news-mental-health","US","\u002Fcategory\u002Ffox-news-us","a1fb12df-5218-5924-8518-5a3af18dbe90","content\u002Ffb\u002Fperson\u002Fd\u002Fbreck-dumas","breck-dumas","Breck","Dumas","https:\u002F\u002Fwww.foxbusiness.com\u002Fperson\u002Fd\u002Fbreck-dumas","\u003Cp\u003EBreck Dumas is a reporter for Fox Business and Fox News Digital.\u003C\u002Fp\u003E\u003Cp\u003EYou may email Breck at \u003Ca href=\"mailto:Breck.Dumas@fox.com\" target=\"_blank\" rel=\"noopener noreferrer\"\u003EBreck.Dumas@fox.com\u003C\u002Fa\u003E, find her on Twitter \u003Ca href=\"https:\u002F\u002Ftwitter.com\u002Fbreck_dumas\" target=\"_blank\"\u003E@Breck_Dumas\u003C\u002Fa\u003E, or contact her on \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fbreck-dumas-a9785b9b\u002F\" target=\"_blank\"\u003ELinkedIn\u003C\u002Fa\u003E.\u003C\u002Fp\u003E","\u002Fhealthcare","9fc2d0f2-fc99-5ae5-a7ec-357ab40ef742","content\u002Ffb\u002Fperson\u002Fg\u002Fdaniella-genovese","daniella-genovese","Daniella","Genovese","https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fdaniella-alessandra-genovese-b843769b","FOX Business","\u003Cp\u003EDaniella Genovese is a consumer and business reporter for Fox Business and Fox News Digital. \u003C\u002Fp\u003E","Food and Drinks","Writer","Retirement","Money & Policy","Inflation","\u002Fcategory\u002Finflation","\u002Fstocks","Futures & Commodities","Pre-Markets","Rich & Famous","Food & Drinks","Personal","Commercial","\u002Fcategory\u002Fspace-business","NFL","\u002Fcategory\u002Fnfl","NBA","\u002Fcategory\u002Fnba","MLB","\u002Fcategory\u002Fmlb","NASCAR","\u002Fcategory\u002Fnascar","Boxing","\u002Fcategory\u002Fboxing","Soccer","\u002Fcategory\u002Fsoccer","Golf","\u002Fcategory\u002Fgolf","Tennis","\u002Fcategory\u002Ftennis","Sports","\u002Fsports","Opinion","\u002Fopinion","Channel Finder","\u002Fchannel-finder","https:\u002F\u002Fwww.foxcareers.com\u002F","Terms of Use","Updated Privacy Policy","FAQ","https:\u002F\u002Fhelp.foxbusiness.com\u002Fhc\u002Fen-us\u002Fsections\u002F4405278462107-FAQ","Media Relations","https:\u002F\u002Fpress.foxbusiness.com\u002Fmedia-contacts\u002F","Corporate Information","https:\u002F\u002Fpress.foxbusiness.com","\u002Fclosed-captioning","Accessibility Statement","\u002Faccessibility-statement","Fox News","https:\u002F\u002Fwww.foxnews.com\u002F","Fox Nation","https:\u002F\u002Fnation.foxnews.com\u002F","Fox Business Go","https:\u002F\u002Fwww.foxbusiness.com\u002Fvideo\u002F5640669329001","Apps & Products","\u002Fapps-products","About","\u002Fabout-us","featured-ad",Array(1),"fox-news-medications","fox-news-weight-loss","fox-news-obesity","fox-news-heart-health","spark_tags","fox-news-lifestyle",{},"\u002Fcategory\u002Ffox-news-obesity","\u002Fcategory\u002Ffox-news-heart-health","articles","2024-03-09T07:54:47-05:00",Array(36),"6347778473112","Weight loss drugs will exceed $100B in annual sales by 2030: Barbara Ryan","16807123-66da-5b01-9e6c-c2ba0a73599d","NVO","NOVO NORDISK A\u002FS","external_stocks","foxbusiness.com\u002Fquote?stockTicker=nvo","23e45f17-769b-5720-b259-e1d0a0c73997","2024-02-27T21:43:44Z","Brightcove","3601801609001","on_air|making_money_with_cpayne","foxbusiness.com\u002Fperson\u002Fp\u002Fcharles-payne","https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F02\u002Fmaking-money.png","https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F02\u002Fmaking-money-poster.png","https:\u002F\u002Fstatic.foxbusiness.com\u002Ffoxbusiness.com\u002Fcontent\u002Fuploads\u002F2024\u002F02\u002Fmaking-money-banner.png","2024-02-26T10:48:46-05:00","2016-12-19T10:01:31-05:00","show","making-money-with-charles-payne","foxbusiness.com\u002Fvideo\u002F6347778473112","MP4",112552573,"https:\u002F\u002Fcf-images.us-east-1.prod.boltdns.net\u002Fv1\u002Fstatic\u002F854081161001\u002F8a599a9a-53dd-43a2-8ff7-b1e5162b025a\u002Faa103c6a-d7ed-4f8c-b99c-6f1c4e6d1206\u002F160x90\u002Fmatch\u002Fimage.jpg","technology","ffceff27-678a-57eb-bf4f-f8b6121f500f","What To Watch","9d44f2e3-6444-523a-a726-55e21d9bba16","Shows","cf464226-cfc8-5db2-8edd-8a21ae49f09a","Making Money with Charles Payne | Latest Episodes","026f94d3-9a08-55a0-b4b7-205790f73968","db347ef2-4af6-5065-b112-5b8709cab346","fox-business\u002Fmarkets","ad76a26e-c3a5-5f15-bd2b-e0c0cac5fe78","Wall Street","3cee0141-e82e-5234-a23f-77b30c385a78","Health Care Tech","b89a3011-beff-5b44-9b5e-c5efc28f2694","ad7aa6c7-d1ff-588f-b455-af12d9519b96","Mergers and Acquisitions","foxbusiness.com\u002Fcategory\u002Fmarkets","4160d163-b4f5-57b6-a294-a7b7169f49cd","Disney","foxbusiness.com\u002Fperson\u002Fn\u002Ftimothy-hj-nerozzi","Timothy Nerozzi","Artificial intelligence","FOOD","\u002Fcategory\u002Ffox-news-food","foxbusiness.com\u002Fperson\u002Fn\u002Fgreg-norman","Greg Norman","\u002Fcategory\u002Fjobs","Media","\u002Fmedia","Coronavirus","\u002Fcategory\u002Fcoronavirus","foxbusiness.com\u002Fperson\u002Fh\u002Fgabriel-hays","Gabriel Hays","\u002Fsmall-business","foxbusiness.com\u002Fperson\u002Fd\u002Fmichael-dorgan","Michael Dorgan","Product Recalls","foxbusiness.com\u002Fperson\u002Fa\u002Fpilar-arias","Pilar Arias","Politics","\u002Fcategory\u002Fpolitics","foxbusiness.com\u002Fperson\u002Fr\u002Feric-revell","Eric Revell","foxbusiness.com\u002Fperson\u002Fr\u002Flawrence-richard","Lawrence Richard","Production Assistant","Government And Institutions","\u002Fcategory\u002Fgovernment-and-institutions","foxbusiness.com\u002Fperson\u002Fs\u002Fshiv-sudhakar","Shiv Sudhakar","foxbusiness.com\u002Fperson\u002Fc\u002Fhaley-chi-sing","Haley Chi-Sing","foxbusiness.com\u002Fperson\u002Fp\u002Fstepheny-price","Stepheny Price","New Terms of Use","footer_termsofuse","New Privacy Policy","footer_privacypolicy","Your Privacy Choices","footer_privacychoices","https:\u002F\u002Fprivacy.foxbusiness.com\u002Fmain\u002Fweb\u002Fmain","Help","footer_help","https:\u002F\u002Fhelp.foxbusiness.com\u002Fhc\u002Fen-us","footer_closedcaptioning","\u002Fclosed-captioning\u002F",{},{}));</script><script src="/_wzln/d848a9c.js" defer></script><script src="/_wzln/b4045d4.js" defer></script><script src="/_wzln/bcd5298.js" defer></script><script src="/_wzln/46ccc55.js" defer></script>
    <script type="text/javascript">!function(i){i.Loader&&i.Loader.init()}(window.FNC||{})</script>
  </body>
</html>
